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ABSTRACT
THE CLINICAL CORRELATES OF BIOLOGICAL
MEASURES OF DEPRESSION

SEPTEMBER 1989
JAN

E.

LERBINGER, B.A., BOSTON UNIVERSITY

M.S., UNIVERSITY OF MASSACHUSETTS

Directed by: Professor Bonnie

R.

Strickland

Relationships between four biological measures (post-

dexamethasone Cortisol, urinary free Cortisol (UFO, 3-methoxy-4-

hydroxyphenylglycol (MHPG), platelet monoamine oxidase activity
(MAO)) and clinical symptoms of depression were examined in a

total group of 83 drug free depressed patients (62 female, 31
male), a subgroup of 67 unipolar major depressed patients, and in

female and male patients within these two groups. Patients were

rated using the Hamilton Rating Scale for Depression (HRSD), the
Schedule for Affective Disorders and Schizophrenia (SADS), and
were diagnosed using Research Diagnostic Criteria (RDC) or other

clinical data.

Data were analyzed using Spearman correlations,

multiple regression analyses, discriminant function analyses,
analysis of variance, and Chi Square.
Overall, stronger relationships were observed between the

biological measures and specific clinical symptoms than with
global ratings of either endogeneity or severity of illness.
Several variables were observed to be significantly correlated

with the biological measures in the unipolar group of patients

iv

but not in the total group, and in some cases stronger

associations were observed in the unipolar group as compared to
the total group of patients. A greater number of significant

correlations were observed between the biological measures and
clinical symptoms in the female group of patients than in the
male subgroup.

Post-dexamethasone Cortisol was most strongly positively
related to psychosis, and negatively to somatic anxiety, and
guilt. Urinary free Cortisol was most strongly negatively

associated with overt anger, subjective anger and agitation, and

positively with suicidal tendencies. The strongest relationships
between MHPG and clinical features were observed in a positive

direction between MHPG and agitation and obsessionality. Platelet
MAO activity was most strongly negatively associated with somatic
anxiety, somatic symptoms and paranoia, and positively with

current suicidality. Of the four biochemical measures, only

platelet MAO activity was observed to be significantly higher in
patients with higher ratings of current suicidality (using the
HRSD suicide item) in comparison to patients with lower ratings
of current suicidality. Overall these data point to complex

relationships between biological measures and clinical
correlates.
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CHAPTER

I

INTRODUCTION

Major depressive disorder is a complex psychobiological

syndrome with multiple etiologies and presentations. The
disorder
involves mood disturbance, various neurovegetative signs, and

often cognitive changes. Physiological theories of major
depressive disorder have examined impairment of brain

neurotransmitters and hormonal systems, as well as circadian

rhythm and REM sleep (Schulberg et al., 1987). Recently, attention
has been paid to clinical laboratory tests which serve as

biological measures of depression. Determining the relationship

between these biological measures and major depression

is

an

important area of research, one that has been limited by the

seemingly broad label of major depression. Attempts to look at

specific major depressive subtypes have been limited by questions
of the validity of these subtypes (Davidson et al., 1985;

Zimmerman et al., 1985), the heterogeneity of major depressions
(Nelson

&

Charney, 1981; Schatzberg et al., 1982), and the

continuing question of whether laboratory findings relate more to
syndrome than to specific symptoms or overall severity.

Information gained from research in this area may help to
elucidate the etiology of major depressive disorders, as well as
aid in determination of effective mechanisms for treatment

(Redmond et al.,

1986).

1

Several biological measures of depression have been
the
focus of study. The dexamethasone suppression test (DST) has
been
one of the most extensively researched, and has been used to

evaluate dysfunction of the hypothalamic-pituitary-adrenal (HPA)
axis in depressed patients. The measure of urinary free Cortisol

(UFO has also been used

to evaluate HPA dysfunction and has the

advantage of providing an integrated measure of Cortisol secretion
over time. Another line of investigation has been the measurement
of disturbances of noradrenergic neurons in the central nervous
system. One such measure is 3-methoxy-4-hydroxyphenylglycol
(MHPG), the major metabolite of norepinephrine in the brain.

Platelet monoamine oxidase (MAO), the enzyme that deaminates

catecholamines and indolamines has also attracted considerable
interest as a biological marker of depression.
While much research has been conducted on these biological
measures,

few have related the findings to the clinical

characteristics of major depressive disorder. Of the studies which
have examined the relationship of these measures to clinical

phenomena, most have focused on an endogenous or melancholic

depressive syndrome. This approach may have limitations, however,

resulting from

a lack, of

agreement among researchers in the

clinical diagnosis of endogeneity or melancholia, despite the aid
of operational definitions (Davidson et al., 1986; Zimmerman et
al,

1986). Casper et al.

(1986)

for example,

found that "the

classic somatic symptoms of depression were present in most

2

.

Research Diagnostic Criteria (RDC) subtypes, and were not

exclusively associated with the endogenous subtype"

(p.

1098).

The uncertainty in clinical diagnosis, and the confounding

effect of severity of depression in both the diagnosis of

endogenous depression (Kumar et al., 1986), and the biological

abnormalities themselves, may in part account for the discrepant
findings in studies relating biological measures to clinical

diagnosis (Davidson et al., 1985). An alternative to the study of

diagnostic subtypes is to examine the relationship between
biological variables and specific signs and symptoms of major

depressive disorder (Davis et al

.

,

1981). For example, a promising

area of research has been the study of the relationship between

biological measures of depression and suicide. While this has

proved a worthwhile avenue of investigation, Ross (1986) warns

against "dealing with symptoms or syndromes as if they were
specific diseases" reflecting "specific biological entities"

(p.

431)
A review of the major literature concerning relationships

between biological measures of depression and endogeneity,
severity of illness, and specific endogenous or nonendogenous
symptoms will be provided. Suicide will be discussed separately,
as it is of greater clinical significance than other nonendogenous

symptoms. A review of the previous literature may point to the

between
most useful approach for further study of the relationship
depressive
biological measures and clinical features of major
disorder.

3

Dexameth asone suppressj^ n t?gt

The dexamethasone suppression test has received
widespread

attention in psychiatry since Carroll et

al

.

(1981)

first

presented data on the standardization of this test in melancholic,
other psychiatric, and normal control subjects. The DST is

generally considered a state marker of depression, and following
the paper of Carroll et al.

(1981), most researchers have defined

an "abnormal" DST or "non-suppression" as a post-dexamethasone

Cortisol level above

5

ug/dL, while a level below

5

Fg/dL is

defined as DST "suppression". The extensive interest in the DST
has resulted in considerable debate regarding its usefulness in

clinical practice.

In a review article in which Arana et al.

(1985) examined 232 citations involving 4,463 psychiatric cases,
it was concluded that

"neither uncritical enthusiasm nor excessive

skepticism about the DST presently is warranted" (Arana et al.,
1985, p.

1200).

Much of the research on the DST has focused on the

relationship between non-suppression of Cortisol and the

melancholic or endogenous subtype of depression (Braddock, 1986;
Carroll et al., 1981). Carroll et al.

(1981) originally reported

that the use of the DST as a laboratory diagnostic test for

melancholia had a "sensitivity greater than 66%" and a
"specificity and diagnostic confidence close to 95%"

(p.

22).

Subsequent reports have provided conflicting evidence. Several
studies have found

a

significant increase in the nonsuppression

4

,

rate among endogenous patients (Coryell et al.,
1982; Feinberg

Carroll, 1984; Zimmerman et al., 1985; Zimmerman et
al

.

,

&

1986;

Zhou et al., 1987). Other data suggests that DST
non-suppression
is not specific to melancholia or endogeneity as a
diagnostic

state (Berger et al., 1982; Miller
1983; Roy et al

.

,

1984;

&

Nelson, 1987; Nasr et al

.

Rubin et al., 1985). As discussed

previously, these conflicting results are in part attributable to
a lack, of diagnostic consistency.

Braddock (1986) reports that

"the criteria employed by the Newcastle Scale and by Carroll's

group seem more successful" at identifying endogenous patients
showing a higher rate of nonsuppression, "than the present state

criteria of the RDC, DSM-III, and ICD"

(p.

367).

One possible explanation for the association of non-

suppression on the DST and endogenous depression

is

that

endogeneity is confounded with severity of illness (Kumar et al.,
1986)

,

with endogenously depressed patients being more severely

depressed than nonendogenous patients (Braddock, 1986). Several
studies have reported a positive relationship between severity of
illness and DST non-suppression (Baumgartner et al., 1986; Brown
et al.,

1979), as well as positive correlations between post-

dexamethasone Cortisol values and severity of illness (Davis et
al.,

1987)

1981;
.

Kumar et al.,

1986; Maes et al.,

1986;

Zhou et al.,

Other evidence has suggested a lack of association between

either non-suppression on the DST or post-dexamethasone Cortisol
levels and severity of illness (Berger et al., 1982; Brown
Shuey,

1980;

Larsen et al

.

,

1985). Despite the conflicting

5

&

.

.

findings, Braddock (1986) concludes that "the evidence so far
does

suggest a relationship between Cortisol level and severity"

(p.

367)

The study of specific symptoms and their relationship to the

DST has been an important area of research. Miller & Nelson (1987)

found that individual symptoms were more closely associated with

DST results than were subtypes, severity or behavioral factors.

Several studies have examined the association between the DST and

symptoms which serve as criteria for the RDC subtype of endogenous
depression. These criteria as defined by Spitzer et al.

(1978)

are: distinct quality to depressed mood, lack of reactivity to

environmental changes, mood regularly worse in morning, pervasive
loss of interest or pleasure, self reproach or guilt, early

morning awakening, psychomotor retardation or agitation, weight
loss and loss of interest and pleasure (nonpervasive)

Positive relationships between the DST and specific

endogenous symptoms of depression have been found. Studies which
have examined these relationships are summarized in Table
11),

1

(p.

and are discussed in greater detail here. Reus (1982)

reported that "independent of diagnosis, non-suppressors are noted
to have a greater

incidence of classical endogenous signs of

dysfunction on admission and a greater incidence of subjective
complaints"

(p.

317).

Among the differences Reus (1982) reported

were increased sleep disturbance, anergy, agitation, loss of
interest, and self reproach in the non-suppressors as compared to
the suppressors.

(1982) described "hypothalamic

Asnis et al.

6

signs" consisting of insomnia, poor appetite, psychomotor

retardation and worsening of mood in the morning, and reported
that these symptoms were significantly higher in non-suppressors.

Rubin et al.

(1985)

found that post-dexamethasone Cortisol values

were positively correlated with observed psychomotor retardation,
lack of responsiveness during the interview, weight loss,

diminished work and activities and insomnia. In addition, nonsuppressors had significantly more terminal insomnia (early

morning awakening) and diurnal variation than suppressors.

Christensen et al

.

(1986) reported an association between post-

dexamethasone Cortisol levels and the HDS-6

(a sum of the

Hamilton

Rating Scale for Depression (HRSD) items depression, guilt, work
and interests, retardation, anxiety psychic and somatic general),
as well as a positive correlation between retardation (sum of

items work and interests and retardation). Several other

researchers have noted a positive association between psychomotor

disturbance (retardation or agitation) and either non-suppression
on the DST or post-dexamethasone Cortisol levels (Agren & Wide,
1982;

Zimmerman et al

.

,

1986).

Reports also exist of a lack of relationship between the DST
and endogenous symptoms (see Table

1,

p.

11).

Asnis et al.

(1982)

did not find that suppressors and non-suppressors differed in

endogenous features. While Brown and Shuey (1980) noted that
suppressors had greater diurnal variation, they also reported that
suppressors and non-suppressors did not differ in the endogenous
symptoms of agitation, retardation or insomnia. Kaspar & Beckmann

7

(1983) also failed to find differences between suppressors
and non-

suppressors on measures of retardation, agitation, work
and
interests, and Brown & Quails (1981) reported no differences

between these groups on measures of appetite loss, guilt,
insomnia, psychomotor activity, weight loss, diurnal variation,

and mood. Finally, Grunhaus et al.

(1985) did not find any

significant relationship between post-DST plasma Cortisol and
either early morning awakening or diurnal variation.

Nonendogenous symptoms of depression have also been the focus
of study. Major findings from these studies are summarized in

Table

1

(p.

11).

Several researchers have examined the

relationship betwen anxiety and post-dexamethasone Cortisol
levels. Positive relationships have been reported between non-

suppression on the DST and anxiety in some studies (Ceulemans et
al.,

1985; Christensen et al.,

1986; Reus, 1982), but not in

others (Asnis et al., 1982). Brown

&

Shuey (1980) and Brown &

Quails (1981) found significant differences between suppressors
and nonsuppressors in the ability to complete self-rating forms,

with the non-suppressors being more unable to complete the forms,
and exhibiting a greater degree of helplessness. Silberman et al.
(1985)

found, contrary to expectation, that suppressors showed a

larger degree of cognitive impairment than non-suppressors.
There does not appear to be consistent evidence regarding the

relationship of the DST to either specific endogenous or

nonendogenous symptoms of depression. In the attempt to elucidate
the relationship between specific clinical signs and symptoms and

8

dysfunction of the HPA system as measured by the DST, two
studies
(Nasr et al

.

,

1983:

Zimmerman et al., 1985), have used a different

methodological approach, conducting discriminant function analyses
on their data.

Zimmerman et al

.

(1985) attempted to develop a discriminant

function that "maximally differentiated between suppressors and

non-suppressors"

(p.

200) on the DST.

discriminant function analysis on the

They conducted the
10

RDC criteria for the

endogenous subtype, using DST results as the independent variable.
They found that only five of the ten endogenous symptoms were

significant contributors to the discriminant function separating
suppressors and non-supppressors

.

Four of the five symptoms were

scored in the positive direction (mood worse in morning, middle or
terminal insomnia, psychomotor disturbance, poor appetite), and

only one symptom (pervasive or non-pervasive anhedonia) was

weighted negatively.
While Zimmerman et al

.

(1985) limited their study to

endogenous symptoms, Nasr et al.
the HRSD in their analysis.

(1983)

included all the items on

In an attempt to "test the hypothesis

that the DST accurately identifies distinct subgroups of clinical

depression having particular signs and symptoms as measured by the
HRSD" (p. 572), Nasr et al. were able to classify patients into

suppressors and non-suppressors with an accuracy of 92.5%. "The
items that identified the non-suppressors in decreasing power were

late insomnia, obsession-compulsion, retardation, psychic anxiety,

and loss of insight. The items that accurately identified the

9

suppressors were depressed mood, hypochondriasis,
weight loss and

depersonalization"

(p.

572).

Although the number of subjects in the Nasr et al.

(1983)

study was considerably smaller (N=40) than that of the
Zimmerman
et al.

(1985) study (N=257), and could have affected the validity

of the results, the Nasr et al. study, does suggest the importance

of including nonendogenous as well as endogenous variables in
future analyses. The recent study by Miller & Nelson (1987) also

supports this conclusion. They reported that DST nonsuppression
was associated with certain "vegetative" signs of depression

(initial insomnia, agitation, loss of sexual interest and weight
loss), but not with the "psychological" symptoms (loss of

interest, anhedonia and guilt).

10

Table

1

STUDIES OF THE RELATI ONSHIP BETWEEN POST-nKX AMETHASONP:
AND ENDOGENOUS AND NONENDOGENOUS SYMPTOMS

~

Study

Findings

Reus (1982)

Asnis et al

.

(1982)

Rubin et al

.

(1986)

Christensen
et al.

(1986)

Agren & Wide
(1982)

Zimmerman et
al.

(1986)

Asnis et al.
(1982)

rnPTT.qnT.

Non-suppressors on DST had
increased sleep disturbance,
anergy, agitation, loss of
interest, self reproach, and
anxiety as compared to suppressors

N = 118

Non-suppressors on DST had
increased insomnia, poor
appetite, and psychomotor
retardation

N = 30
lo Males

Post-dexamethasone Cortisol
positively correlated with
psychomotor retardation, lack.
of responsiveness during interview,
weight loss, and diminished work and
activities; non-suppressors had
increased early morning awakening
and diurnal variation

n = 64
31 Males

Significant association between
post-dexamethasone Cortisol
and HSD-6 score,
retardation, and psychic anxiety

N = 35

Non-suppression on DST associated
positively with summed score of
agitation and retardation

N = 51

DST results positively related
to psychomotor disturbance

N

Non-suppressors and suppressors
on DST did not differ in
severity of endogenous features

20

Females

33 Females

12 Males
23 Females

N

11

= 257

= 40

Males

29 Females

^ HDS-6 = A sum of Hamilton Rating Scale

for Depression items
retardation,
activities,
depression, guilt, work and
general
anxiety psychic, and somatic

continued next page
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Table

1

(continued)

STUDIES OF THK RE LA T IONSHIP BETWEEN Pne^T-Q EXftMRTHftsnMir
ft«MHi^ SONE rORTTSOL
CORTISOL
AND ENDOG E NOUS AND MQMEMnOfiRMQ US Svi^F^

Study

Findings

Brown & Shuey
(1980)

Kaspar &
Beckman (1983)

Brown

&

Quails

(1981)

Suppressors on DST had greater
diurnal variation; no difference
between suppressors and nonsuppressors on ratings of
agitation, retardation or
insomnia; non-suppressors were
more unable to complete rating
forms and had greater degree of
helplessness

N = 49
39 Males
lo

Females

No difference between suppressors
and non-suppressors on measures
of retardation, agitation, and
work and interests

N = 67

No difference between suppressors
and non-suppressors on measures of
appetite loss, guilt, insomnia,
psychomotor activity, weight loss,
diurnal variation and mood; non-

N = 39

15 Males

52 Females

8

Males

31 Females

suppressors more unable to complete
rating forms and had greater degree
of helplessness

Grunhaus et al
(1985)

No significant relationship between
post-dexamethasone Cortisol and
either early morning awakening or

N = 49

diurnal variation

Ceulemans
et al. (1985)

Higher levels of anxiety in DST
non-suppressors than in controls

Silberman et

Suppressors showed larger degree of
cognitive impairment than nonsuppressors

N = 27

Psychomotor retardation and
depressed mood significantly
greater in non-suppressors

N = 187

al.

(1985)

Zimmerman et
al.

(1986)

12

N = 40
23 Male
17 Female
20 controls

8

Males

19 Females

65 Males
132 Females

Dexamethasone suppression test and suicidp

One of the most extensively researched areas in
the

examination of the relationship between clinical characteristics
of depression and altered biochemistry, has been the study
of

suicide and suicidal behavior. Several studies have examined the

association between suicidal behavior and HPA dysregulation as
measured by the DST. These studies have included suicide
completers, suicide attempters, and suicide contemplators

.

While

these groups may appear to be distinct, they may in fact represent
a continuum of suicidality.

Stallone et al.

(1980)

for example,

found that "attempters and contemplators were a good deal more

similar to one another than either one was to the nonsuicidals"
(p.

386).

Several studies have found a relationship between suicide and

non-suppression on the DST. Coryell

&

Schlesser (1981) in one of

the few studies to examine biological abnormalities in suicide

completers, found a higher incidence of suicide completion in

patients with abnormal DST's. Due to the length of time however

between the DST and the actual suicide completion, these results
must be regarded as equivocal. Others have examined past suicide
attempts, and have found a greater rate of non-suppression in

suicide attempters vs. non-attempters (Banki et al., 1984; Targum
et al.,

1983), and in "violent and nonviolent

"

attempters vs.

nonsuicidal patients (Banki et al., 1984). Reus (1982), in the one
study to find a positive association between the DST and

13

.

suicidal ity assessed at the time of biochemical measurement,

reported that DST non-suppression was associated with
"increased thoughts of suicide", thus suggesting the relationship

between HPA dysfunction and suicide "contemplators"
Other researchers have failed to confirm the positive

association between DST non-suppression and either past or present
suicidal ity. Secunda et al.

(1986)

found no significant

differences between suicide attempters and non-attemptors in postdexamethasone Cortisol levels. They did find significantly lower

pre-dexamethasone levels in the suicide attempters however. Brown
et al.

(1986) studied three groups of patients: patients who had

recently attempted suicide (within 28 days before the DST), past
attempters, and non-attempters, and found that plasma Cortisol
levels did not differ significantly between the three groups. They
also found that there were no significant differences in mean

Cortisol levels between "patients rated as having active suicidal
intent" (on HRSD suicide item) and "patients with passive or no

suicidal ideation"

(p.

319).

Zimmerman et al.

(1986) reported that

there were no significant differences between suppressors and non-

suppressors on the DST in either frequency of past suicidal
thoughts or serious past suicide attempts. They did find that past

nonserious suicide attempts were significantly more frequent in
the suppressors.
The positive relationship between HPA dysfunction and

suicidality has not been well documented. Further research may
help to clarify whether the tendency of depressed patients to

14

attempt suicide may be exacerbated by an underlying
neurobiological disorder reflected by HPA dysregulation,
and
whether depressed suicidal patients with abnormal
DST's may

represent a high-risk group for recurrence of suicidal
behavi

Urinary Free Cortisol

Urinary free Cortisol (UFO, an integrated measure of
Cortisol over time, has also been used to evaluate HPA dysfunction
and may have the potential to yield more information than can be

obtained from occasional blood samples. The study of UFC however,
has received much less research attention than the DST. Studies

examining UFC in patients with major depressive disorder
have generally found elevated levels of UFC as compared to

"normal" controls or patients with other psychiatric disorders
(Carroll et al.,

1976;

Rosenbaum et al., 1983).

Few studies have been conducted which examine the

relationship between UFC and endogeneity, severity, specific
endogenous symptoms, or nonendogenous symptoms. Those studies
which have examined the relationship between UFC and specific

endogenous or nonendogenous symptoms are summarized in Table
17).

Berger et al.,

2

(p.

(1982) did not find a significant difference

between endogenous and nonendogenous patients in UFC levels.
Kathol (1986) studied recovered depressed patients and controls,

and found a positive correlation between

15

Beck.

Depressive symptoms

.

and UFC in the group of recovered patients, but not in
the

controls. Agren & Oreland (1982) reported a significant
positive

relationship between early morning awakening and UFC, and Berger
et al.

(1982)

found a positive association between UFC and weight

loss
The study of the relationship between suicide and UFC has

also received little attention. Agren

&

Wide (1982) reported that

UFC was highly significantly correlated with less past suicide
proneness. In addition they found that 20% of the variance of UFC
was explained by the Schedule for Affective Disorders and

Schizophrenia (SADS) items of "seriousness plus medical lethality
of worst ever suicide attempt",

"anger worst week.", and "overt

anger last week". UFC was also found to correlate negatively with
anger scores. This study points to the important relationship

between suicide and expression or experience of anger.
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Table

2

STUDIES OF THE RELATIONSHIP BETWEEN UFC AND ENDOaFMnnq AND
NONENDOGENOUS SYMPTOMS
'

Study
Kathol et al.
(1985)

Findings
Positive correlation between
UFC and Beck Depression Inventory
score in recovered depressed

N
N

= 7

patients

Agren &
Oreland (1982)

Berger et al.
(1982)

Positive correlation between
UFC and early morning awakening

Positive association between
UFC and weight loss
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N = 51

22 Males
29 Females

= 45
22 Males
23 Females

N

)

3-methox v-4-hvdroxvDhenYl glycol

(

MHPn

MHPG, the major metabolite of norepinephrine from the brain,

has been measured in plasma, urine, and cerebrospinal fluid (CSF).

Although a substantial portion of plasma and urinary MHPG may be
of peripheral origin (Halbreich et al

.

,

1987), with the exact

fraction of urinary or plasma MHPG derived from the brain

uncertain (Schatzberg et al

.

both urinary and plasma MHPG

,

1982),

it is generally agreed that

"have their place in psychiatric

research" (Filser et al., 1986,

p.

96).

MHPG has been studied in relation to the monoamine hypothesis
of depression which has suggested that depression is caused by

insufficient activity of monoaminergic neurons. Studies examining
MHPG in major depressive disorder have found differences in

urinary MHPG in various subtypes of depressive disorders
(Schildkraut et al., 1978; Schatzberg et al., 1982), as well as
higher CSF MHPG levels in depressed subjects as compared to

controls (Koslow et al., 1983).
One study has reported on MHPG and its relationship to

endogeneity. Nelson and Charney (1981) comment that "decreased
MHPG may be specific to endogenous depression". More has been

written about MHPG in relation to severity of illness. The
majority of reports have failed to find a significant relationship

between severity and MHPG as measured in urine (Davis et
al.,1981), plasma (Roy et al., 1986) and CSF (Redmond et al..
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1986). Recently however, Schatzberg et al

(1989)

.

found a

significant main effect for severity on MHPG, with the more
severely depressed patients having higher MHPG values.
Several studies have suggested a positive relationship

between MHPG and endogenous symptoms.
is

presented in Table

3

21).

(p.

A summary of these studies

Agren (1980) found

a

significant

positive correlation between CSF MHPG and both "distinct quality
of mood" and "lack of energy". Redmond et al.

(1986) reported that

sleep disturbance was significantly correlated with CSF MHPG in

depressed patients, and found that depressed patients with
"higher" retardation scores had significantly higher CSF MHPG

concentrations than patients with "low" or "middle" retardation
scores.

Nonendogenous symptoms of depression have also been studied
in their relationship to measures of MHPG (see Table

3,

p.

21).

Positive associations between MHPG and anxiety have been reported
(Roy et al.,

1986; Redmond et al.,

In addition, depressed

1986).

patients with increased somatization have been found to have
higher levels of CSF MHPG

(

Redmond et al

.

,

1986).

In contrast to

these findings, a study of afternoon continuous plasma levels of

MHPG (Halbreich et al

.

,

1987)

found almost no association between

plasma MHPG and clinical symptoms.
Overall, the research examining MHPG in relation to

endogeneity, severity, and specific endogenous and nonendogenous
symptoms, does not appear to provide a consistent picture. Using a

somewhat different methodological approach to examine the clinical
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correlates of MHPG, Agren (1980), using
symptom scores on the
SADS, performed a series of multiple regression
analyses. His

results revealed that "high- and low-MHPG
syndromes could be
isolated"

(p.

211).

In his sample of unipolar patients,
Agren

identified a "high-MHPG syndrome characterized by
Lack of Energy,

Overt Anger, Self Pity and Somatic Preoccupation",
and a "low-MHPG
syndrome" characterized by "Discouragement, Demandingness,

Subjective Anger, Suicidal Tendencies, Indecisiveness, and

Obsessions-Compulsions"

(p.

218). Again, the use of a more complex

method of data analysis suggests the importance of examining both

endogenous and nonendogenous symptoms simultaneously.
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Table

3

~

STUDIES OF THE RELRTIQNSHIP BETWEE N MHPG AND FMnnr.FMnnQ
and
'
NONENDOGENOUS SYMPTOMS

Study

Findings

Agren (1980)

Redmond et al
(1986)

Roy et al

.

(1986)

Halbreich et
al.

(1987)

.

Significant positive correlation
between CSF MHPG and distinct
quality of mood and lack of
energy

N = 33
12 Males

CSF MHPG significantly and
positively correlated with sleep
disturbance; patients with higher
retardation scores had significantly
higher CSF MHPG levels than patients
with "low" or "middle" retardation
scores; positive correlation between
MHPG and anxiety; patients with
increased somatization were found to
have higher levels of CSF MHPG

N = 99

Positive correlation bewteen plasma
MHPG and anxiety symptoms

N = 51

Almost no association between plasma
MHPG and clinical symptoms

N = 42

21 Females

11 Males
40 Females

15 Males
27 Females
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MHPG and suicide

Most of the work exploring the relationship between suicide
and the metabolites of monoamine neurotransmitters has focused on

associations between low levels of the serotonin metabolite, 5-

hydroxindoleacetic acid (5-HIAA) in CSF, and suicidal behavior
(Agren,

1980; Asberg & Traskman,

1981).

As a result,

less

attention has been paid to MHPG, the metabolite of norepinephrine,
and its association to suicide.
Several studies have found a negative relationship between

MHPG and past suicidal ity. Secunda et al

.

(1986) reported that

suicide attempters had significantly lower urinary and plasma MHPG
levels than patients who had never attempted suicide. Agren (1980)
also found a negative correlation between CSF MHPG and suicidal

tendencies occurring during the worst week of the current episode.
(1986) observed an increase in P-adrenergic

Mann et al.

binding in frontal cortices of violent suicide victims as compared
with matched controls, and stated that "this suggests that there
may also be a concomitant reduction in presynaptic noradrenergic

activity associated with suicide"

(p.

954).

In contrast to the findings of a negative association between

MHPG and suicide, Traskman et al.

(1981)

found no significant

difference in MHPG levels between either of two types of suicide
attempters studied (violent vs. nonviolent), and
A positive

a control group.

relationship between CSF MHPG and suicide was found by

Brown et al.

(1982)

in a sample of patients with various
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personality disorders. Brown et al.

(1982)

found that in

particular, patients with histories of aggressive and suicidal

behavior had higher levels of CSF MHPG. This contradictory finding
may in part be explained by the population of patients studied. A

study by Agren (1980) in which it was found that MHPG correlated

significantly with the SADS item "Suicidal Tendencies

also

points to the relationship between suicidal ity and anger or
aggressiveness. Agren (1980)

found that "subjective anger was

positively, and overt anger negatively associated with thoughts of
suicide"(p. 225). Agren suggests that noradrenergic neurons

apparently play a role both in the "conveying" of the emotion of
anger, and in "executing the death wish"

(p.

235).

Platelet monoamine oxidase activity

Platelet MAO is one of the most extensively researched

enzymes in relation to personality traits and psychiatric

disorders (Agren & Oreland, 1982). It has been of particular
interest to researchers in biological psychiatry as it is the

enzyme that deaminates catecholamines and indolamines. It has been

suggested that MAO activity may "provide some indication of the
turnover of monoamines which, as neurotransmitters, may be
involved in the development of depression" (Georgotas et al.,
1986, p.

247).

23

,

While strong relationships have been found to exist between

platelet MAO activity and personality traits, studies
investigating platelet MAO activity in affective disorders have
been less definitive. Several studies have found platelet MAO

activity to be lower in bipolar depressives (Mann, 1979; Murphy
Weiss,

1972) and higher

in unipolar depressives (Reveley et al.,

1981), particularly females (Bridge et al
1983; Mann,

&

.

,

1985; White et al

.

1979).

The relationship between the endogenous or melancholic

subtype and platelet MAO activity has been discussed by several
researchers. Some have found a positive relationship between

platelet MAO activity and endogenous depression. Mann (1979)
discusses the possibility that "altered MAO activity may be
feature of endogenous rather than reactive depression"
and Samson et al.

(p.

a

735),

(1985) report finding significantly higher MAO

in "nonschizotypal unipolar endogenous depressed patients than in

nonschizotypal bipolar endogenous depressed patients, or
nonschizotypal unipolar other patients"
White et al

.

(1983)

(p.

547).

In contrast.

found higher platelet MAO in nonendogenously

depressed females than in female controls. Davidson et al.

(1980)

reported no significant differences in platelet MAO activity

between endogenous and nonendogenous patients, after adjusting for
the effects of age and sex.

The lack of consistency in the studies examining the

relationship between the diagnosis of endogeneity and platelet MAO
activity may again be related to a lack of diagnostic agreement.
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Georgotas et al
years of age,

.

(1986),

for example,

in a study of patients

55

>

found no significant difference in platelet MAO

activity between endogenous and nonendogenous patients
(using RDC
criteria) after the effects of age and sex had been
controlled
for.

However, using the DSM-III criteria for major depression
with

melancholia, they found that melancholic patients had

significantly higher platelet MAO activity than those without
melancholia, after the effects of age and sex were taken into
account.
The possibility of the confounding effects of severity of

illness on the relationship of platelet MAO activity to

endogeneity has been discussed by several researchers. Some
have reported a significant positive correlation between total

score on the HRSD and platelet MAO activity (Gudeman et al.,
1982;, Mann,

1979;

Samson et al., 1985). Samson et al. state that

"the presence of a definite endogenous depressive syndrome was

associated with greater overall symptom severity in both unipolar
and bipolar depressed patients" (p. 547). They suggest that

"unipolar endogenous depression of high severity is characterized
by high platelet MAO activity" (p. 553) as well as nonsuppression

on the DST.
Several studies have reported on the association between

platelet MAO activity and specific symptoms of endogenous
depression. A summary of these studies is presented in Table

4

(p.

28), and discussed in greater detail here. A negative correlation

between platelet MAO activity and guilt has been reported in
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total groups of patients (Perris et al

.

,

1980;

Schalling et al.,

1980), and in females only (Perris et al., 1984) A positive

correlation between platelet MAO activity and guilt has also been
reported (Schalling et al

.

,

1980). Agren & Oreland

(

1982)

found

that unipolar patients with higher levels of platelet MAO activity
woke up earlier than they had before becoming depressed.

Schatzberg et al

.

(1986)

found platelet MAO activity to be

positively associated with early morning awakening, as well as
with difficulty falling asleep, and "middle insomnia". The

endogenous symptoms of anhedonia and mood autonomy were reported
to be positively correlated with platelet MAO activity (Georgotas

et al.,

1986), as were the symptoms of depressed mood, weight

loss, agitation, and decreased energy and activity (Gudeman et
al.,

With the possible exception of guilt,

1982).

it

appears that

most reports find a positive relationship between some of the

endogenous symptoms of depression and platelet MAO activity.
Many of the studies reporting on nonendogenous symptoms of

depression and their relationship to platelet MAO activity (see
Table

4,

p.

28)

have focused on anxiety. Davidson et al

.

(1980)

found platelet MAO activity to correlate positively with anxiety,

and Georgotas et al.

(1986) reported that platelet MAO activity

was significantly related to somatic anxiety, but not to psychic

anxiety. Khan et al

.

(1986) were "unable to demonstrate that MAO-B

activity differentiated among anxious, depressed, or control
subjects"

(p.

848), and found a "poor correlation between MAO-B

and severity of anxiety symptoms"
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(p.

848).

To further explore the relationship between clinical symptoms

and platelet MAO activity, Gudeman et al.

(1982) performed a

multiple regression analysis using 21 items from the Clinical
Inventory for the Diagnosis and Classification of the Affective

Disorders (CIDCAD). They report that "this analysis identified six
clinical items"

(p.

631)

(abdominal heaviness, decrease in social

activity, agitation, decrease in emotional receptivity, weeping
(with a negative coefficient), and the presence of a major stress

precipitant) "each of which accounted for a significant portion of
the variance of MAO activity"

(p.

631).

This statistical approach

may yield results which may prove to be of clinical relevance.

Gudeman et al.

(1982) report that most of the symptoms they found

to be associated with higher platelet MAO activity (both

endogenous and nonendogenous symptoms) "would be included in one
or more of the clinical features"

(p.

532) reported by other

researchers to be responsive to treatment with MAO inhibitors.
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Table

4

STUDIES OF THE RELATIONSHIP BETWEEN PLATF.T.FT MAO ACTTVT TV
AND
ENDOGENOUS AND NONRNDOGENOUS SYMPTOMS
'

Study

Perris et al

Findings

Weak, negative correlation
between platelet MAO activity
and guilt

N = 30
14 Males

Negative correlation between
platelet MAO activity and guilt
in females

N = 143
60 Males
83 Females

Agren &
Oreland (1982)

Unipolar patients with higher
levels of MAO activity woke up
earlier than they had before
becoming depressed

N

Schatzberg et

Platelet MAO activity positively
correlated with early, middle, and
late insomnia

N

Positive association between MAO and
anhedonia, mood autonomy; MAO
significantly related to somatic
anxiety but not to psychic anxiety

N = 67

Positive correlation between MAO and
depressed mood, weight loss,
agitation, decreased energy and
activity

N = 32
18 Males

Platelet MAO activity significantly
higher in depression secondary to
chronic anxiety

N = 88
17 Males
71 Females

No difference in levels of HAO-B
activity between anxious, depressed
or control subjects; poor correlation
between MAO- B and severity of
anxiety symptoms

N

(1980)

Perris et al
(1984)

al.

(1985)

Georgotas et
al.

(1986)

Gudeman et al.
(1982)

Davidson et al
(1980)

Kahn et al
(1986)
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le

Females

= 51
22 Males
29 Females

= 50
23 Males
27 Females

24 Males

43 Females

14 Females

= 163
94 Males
69 Females

.

Platelet MAO activity and suicidp

Several studies have considered the relationship between

platelet MAO activity and past suicidality, and conflicting
evidence has been found. Low platelet MAO activity has been
reported in depressed patients who have made particularly serious
suicide attempts (Gottfries et al., 1980). Buchsbaum et al.

(1977)

found that males with low MAO and AER (averaged evoked response)

augmenting, showed a significantly increased incidence of suicide

attempts in comparison with either non-augmenting low MAO or high
MAO patients. In contrast, Oreland et al.

(1981) did not find any

difference in the level of platelet MAO activity between suicidal
and non-suicidal patients. In a study of brain MAO activity, Grote
et al

.

(1974)

"found no significant difference for MAO activity in

28 brain areas when 19 controls were compared with 14 depressives

suicides or with 11 alcoholic studies" (Reveley et al

.

,

1981, p.

259)

The relationship between platelet MAO activity and suicide

may be complicated by the fact that unipolar and bipolar depressed

patients have been found to have significantly different levels of

platelet MAO activity, as well as different rates of suicide
attempts. Bipolar depressed patients have been reported to be more

likely to attempt suicide than unipolars (Secunda et al., 1986),
and to have lower platelet MAO activity (Mann, 1979; Murphy
Weiss,

1972).

&

Impulsivity and monotony avoidance have also been

in
found to be related to lower levels of platelet MAO activity
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,

both depressed patients and normal controls
(Schalling et al
1980; Perris et al.,

1980; Perris et al.,

1983;

.

Perris et al.,

1984), and perhaps are also associated with bipolar
depression.

Biologica l measures and their inter-relations^)
,p

The majority of studies have focused on the measurement of
one biological measure of depression in a population of patients.

Several studies have examined two or more biological measures, and
have attempted to understand the inter-relationship between

catecholamine systems, HPA activity, and platelet MAO activity.
Studies of severely depressed patients have reported significantly

positive correlations between Cortisol and MHPG as measured in 24hour urine collection or plasma
al.,

1983;

Rosenbaum et al

.

,

(

1983;

Stokes et al., 1981; Jimerson et
Zhou et al.,

1987).

Other studies have examined the relationship of platelet MAO
and HPA activities. Positive correlations have been observed

between platelet MAO and 24-hour urinary free Cortisol in unipolar

depressed patients (Agren

&

Oreland, 1982). In addition, it has

been observed that depressed patients with high platelet MAO

activity are more likely to be DST non-suppressors than are
patients with low platelet MAO activity (Georgotas et al

Hartong et al., 1985), Schatzberg et al
al.,

1985).

.

,

.

,

1986;

1983b; Schatzberg et

Reports also exist of positive correlations between
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platelet MAO activity and post-dexamethasone Cortisol levels
(Meltzer et al.,

1988;

Schatzberg et al

.

,

1987).

Several of the studies examining the relationship between HPA

and platelet MAO activity have found that specific clinical

symptoms have been associated with both biochemical measures
studied. Schatzberg et al.

(1985)

found that both post-

dexamethasone Cortisol levels and platelet MAO activity were

correlated with total HRSD score

(a

measure of severity), and

early, middle and late insomnia. Agren

&

Oreland (1982) reported a

significant positive correlation between both urinary free
Cortisol, platelet MAO activity, and early morning awakening.
Finally, Georgotas et al.

(1986) hypothesized that one reason that

higher MAO activity has been found in DST non-suppressors may be
that anxiety and agitation which have been found to be associated

with higher platelet MAO activity, may also "account for some
cases of DST non-suppression"

(p.

265).

Studies reporting on the clinical correlates of biological

measures of depression often present discrepant findings, and
point to a complex relationship between HPA activity,

catecholamine systems, platelet MAO activity, and specific signs
and symptoms. Many of the studies are complicated by the use of

diagnostic categories, particularly the endogenous, non-endogenous
distinction. Due to the lack of a valid operational definition of

endogenous depression (Zimmerman et al., 1985), this diagnostic
subtype does not consistently identify a homogeneous group of
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patients, and has also been found to be confounded with severity
of illness

(

Kumar et al

.

,

1986).

Studies which organize data from biological measures of

depression around "symptoms and their severity rather than
diagnostic groups" (Davis et al

.

,

1981,

p.

1560) may prove to be

of more potential use clinically. Even more promising are studies

which have used either a multiple correlational approach or

discriminate function in the analysis of their data. These
approaches have allowed researchers to disregard diagnostic
labeling while simultaneously examining both endogenous and

nonendogenous symptoms. Further research
to

is

needed in the attempt

elucidate the relationship between biological measures of

depression and their clinical correlates. Future studies must take
into consideration the effects of sex and age on biological

measures, as well as distinguish between unipolar and bipolar

depressed patients. In addition,

further studies are needed to

measure several biological factors in the same group of people,
and to examine the inter-relationship between these biological

measures, as well as their association with clinical

characteristics.
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Purpose of study

The present study was conducted in order to more fully

explore the relationship between four biological measures (post-

dexamethasone Cortisol, urinary free Cortisol, urinary MHPG,

platelet MAO activity) and clinical symptoms of depression.
The majority of previous studies in which relationships

between biochemistry and clinical symptoms have been examined,
have focused on major depressive disorder without consideration of
subtypes. Most of these studies have also investigated

relationships between clinical features and biological measures in

combined groups of females and males. Despite reports of
associations between biochemical measures and age and severity,
few studies have controlled for these effects.

In this study, associations between biochemistry and

clinical symptoms were studied not only in the total group of
patients, but in a subgroup of patients diagnosed with unipolar

major depression as well. Further analyses were performed on
female and male patients separately.

It was anticipated that

different relationships would be observed between biological
measures and clinical symptoms in the total group of patients as

compared to the unipolar patients, and in the female subgroups as
effects
compared to the male subgroups. In the present study the

determine
of age and severity were controlled for in order to
and clinical
whether relationships between the biological measures
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symptoms would remain after these effects were statistically
removed

Previous research has primarily examined the relationship

between biological measures and endogeneity, severity, endogenous
symptoms, and/or nonendogenous symptoms. In the present study
these relationships were also examined in order to determine

whether the biological measures would relate more strongly to

overall endogeneity and severity, or more

to

specific symptoms of

depression. Both endogenous and nonendogenous symptoms were

studied in an attempt to determine whether endogenous or

nonendogenous symptoms would be more frequently and strongly
related to the biological measures. Based on findings from
previous reports, in the present study it was anticipated that non-

suppressors and suppressors on the DST would be able to be

distinguished from one another on the basis of clinical symptoms,
and that a "high" and "low" MHPG syndrome could be identified.
In the present study the relationship between biological

measures and suicidality was a primary focus. Much of the previous
literature which has examined this relationship has focused on
past suicidality, most often in either suicide victims or suicide

attempters. In the present study both past suicidality (occurring

during the worst week of the current episode), and current

suicidality (occurring during the same week as the biological
measurement) were studied in order to more fully explore the

relationship between suicidality and biological measures, as well
as to determine whether assessment of past or present suicidality
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affected these relationships. This study was also
designed to
examine whether patients with higher ratings of suicidality
would
differ biochemically from patients with lower ratings
of
suicidality.
The present study is one of the few to examine relationships

between clinical symptoms and more than one biological measure. It
was designed to assess different aspects of biological functioning
(HPA activity, noradrenergic activity, platelet MAO activity)

simultaneously in the same group of patients, and to explore
whether the presence of specific clinical symptoms was related to
more than one biological measure.
This study was designed as an exploratory study with the

intention both of confirming or disconf irming previous reports, as
well as suggesting areas for further exploration of the

relationship between biological measures and clinical correlates.
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CHAPTER II

METHODS

This study included 83 patients with
major depressive

disorder (52 female and 31 male) who ranged
in age from 18 to 65
years (mean

i

SD age= 38.5

i

11.5). All patients were medically

and neurologically healthy. Any patient with
marked recent weight

loss of 20% of body weight was excluded (Carroll
et al., 1981).

Subjects did not receive psychoactive medication for
at least

seven days (at least two weeks in the case of two
patients who had

previously been on MAO inhibitors) before blood was drawn
for

platelet MAO determination, with the exception of the

administration of low doses of a benzodiazepine to six patients
for agitation or insomnia. Of these,

four received oxazepam, one

received lorazepam, and another flurazepam.
Informed consent was gained from all participating patients
after a complete explanation of research procedures. Clinical

ratings and biochemical measures were obtained during a one week
period. During this time period, all patients were rated using the

21-item Hamilton Rating Scale for Depression (HRSD) (Hamilton,
1960). HRSD scores ranged from 11 to 39, with a mean

24.2

i

5.4.

i

S.D.

of

Forty-three patients were interviewed using the

Schedule for Affective Disorders and Schizophrenia (SADS).

Patients were diagnosed using Research Diagnostic Criteria (RDC)
(Spitzer et al.,

1978), or other available clinical data. Of the
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83,

67 met criteria for unipolar major depression.

criteria for bipolar disorder. Of those,

5

Sixteen met

were bipolar I, eleven

were bipolar II. Of the 67 unipolar major depressed patients, 47

and sixteen fulfilled criteria for definite and probable

endogenous sub-types respectively. Four were not endogenous.
The presence or absence of psychotic features of depression
was rated clinically on a

3

point scale; a rating of

the absence of psychotic features, a rating of

indicated

the probable

2

presence of psychotic features, and a rating of

1

3

the definite

presence of psychotic features. Seventy-six patients received a

rating of

1,

two patients received a rating of

patients received a rating of

2,

and five

3.

Suicidality was assessed in two ways. Current suicidality
was rated using the HRSD suicide item (item 3), a five point scale

ranging from

0

(absence of suicidal ideation) to

4

(serious

suicide attempt). Twenty-one patients received a rating of

thirty-two a rating of
of

3.

1,

twenty a rating of

2,

0,

and nine a rating

No patients received a rating of four, and one patient had

missing data.
Past suicidality was rated using the SADS item suicidal

tendencies (item 246), which assesses suicidality occurring during
the worst week of the current episode or during the worst week of

(absence of suicidal

the past year.

This item ranges from

ideation) to

(serious suicide attempt). Eight patients received

7

a rating of 1,

of

3,

1

four patients a rating of

sixteen patients a rating of
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4,

2,

ten patients a rating

and one patient each.

ratings of

5,

6,

and

7.

In this study, all clinical ratings were

performed by raters who were blind to the biochemical data.
Each patient had blood samples drawn using a simple needle
stick. Blood samples were drawn between

8

and 9:30 a.m.

a.m.

for

determination of platelet MAO activity. When two platelet MAO
activity levels for a patient were available, mean values were
used in the data analysis. Blood was drawn for the determination
of Cortisol at

4

p.m.

on days

1

and

2

of the study. A

of dexamethasone was given at 11 p.m. on day

1

1

mg.

of the study.

dose
All

patients had at least one MAO level drawn on a day other than that
following the administration of the dexamethasone. Sixty-seven

patients collected 24 hr. urine specimens for MHPG and UFC

determination over a two or three day period. Patients were given
detailed instructions concerning the collection of 24-hour urine
specimens; the completeness of the collection was ascertained by

careful interviews, with specific documentation and recording of

possible urine losses, and by measurements of 24-hour urine volume
and creatinine excretion. Mean values of urinary measurements were
used for data analysis.

Differential centrifugation was used to isolate the
platelets, and platelet MAO activity was determined by measuring

deamination of 12 C-tryptamine bisuccinate by methods described by
Orsulak et al.

(1978) and by Gudeman et al.

(1982); activity is

expressed as nanomoles tryptamine deaminated per hour per mg.
isolated in
protein. On several occasions, levels of MAO activity

centrifugation
platelets that were obtained by this differential
platelets obtained by
method were compared with those levels from
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the Corash procedures (Corash et al.,
1977) and similar values

were observed for platelet MAO activity
(Mooney et al., 1981).

Plasma Cortisol levels were determined with
radioimmunoassay
(RIA) methods, as described by Schatzberg et
al.

suppression was defined as a
level)

5

Hg./dl.

4

Non-

(1983a).

p.m. post-dexamethasone Cortisol

(Carroll et al

.

,

1981;

Schatzberg et al

.

,

1983a).

Total 24-hour urine collections were obtained with
acetic

acid as preservative and aliquots were stored at -20" C until
analysed. Urinary 3-methoxy-4-hydroxyphenylglycol (MHPG) was

determined by electron capture gas chromatography using a

modification of the method of Dekirmenjian and Maas (1970). Under
routine operations, the interassay coefficient of variation was
6.2%.

Urinary free Cortisol was determined by radioimmuno assay

using a commercially available (Amersham Cortisol I^^^

radioimmunoassay system) antibody specific for Cortisol and I^^^
labled antigen following the method described in the NEDH

Laboratory of Pathology Chemistry Procedure Manual. Biochemical

determinations were performed by laboratory personnel blind to the
clinical diagnosis.

Data were analyzed using the Statistical Package for the
Social Sciences (SPSS-X). Separate multiple regression analyses

were performed using each of the biochemical measures as the

dependent variable, and age and severity as the independent
variables in the analyses involving post-dexamethsone Cortisol and
platelet MAO activity, and age, severity, creatinine and total
volume of urine as independent variables in the analyses involving

urinary free Cortisol and MHPG. Standardized residuals from these
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regressions were then correlated with the items from the HRSD and
selected items from the SADS using Spearman correlations. Here
these are referred to as partial correlations. Zero-order Spearman

correlations were also calculated between the biological measures
and clinical symptoms. Only the correlations between the

biological measures and age, severity and endogeneity are

presented here.
Correlations were calculated for the following groups: the
total group of patients, the group of unipolar major patients, and
the group of bipolar patients. Correlations were also computed for

females and males separately within these diagnostic groups. Data
from the bipolar patients are not reported on here, as the small

sample size in the bipolar group, particularly in the female and
male subsets make questionable the interpretation of the results.

Correlations attaining p values of

<

.05 were considered

significant, however, due to the large number of correlations

computed in this study, the Bonferroni correction was applied.
Data were interpreted both with and without this correction (see
Discussion,

p.

68).

Multiple regression analyses were performed after the

computation of the correlation matrices, using each of the
biochemical measues as the dependent variable, and using variables
that had been observed to be significantly correlated with the

specific biochemical measure, as well as age, sex and severity, as
independent variables. Data were also analyzed using analysis of

variance (ANOVA), covarying for age, sex and severity,

discriminant function analyses, and Chi Square.
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CHAPTER III

RESULTS

Post-dey^methasone Cortisol and clinicaT ^y^
P^"""'

Table 5 lists all significant correlations
between post-

dexamethasone Cortisol and clinical symptoms in the total
group of
patients and in the female and male subgroups. In the
total group
of patients (see Table 5, p. 43) guilt was the only
endogenous

symptom to correlate significantly (negatively) with postdexamethasone Cortisol after controlling for the effects of age
and severity. The nonendogenous symptom somatic anxiety was also

significantly and negatively correlated with post-dexamethasone
Cortisol. The presence of psychotic symptoms, and the age of onset

of the illness, were also observed to be positively associated

with post-dexamethasone Cortisol, but age

(r

=

-.17, p = NS) and

severity of illness (r = .20, p = .08) were not significantly
related with post-dexamethasone Cortisol in the total group of
patients. The relationship between post-dexamethasone Cortisol and

endogeneity was stronger than that observed with age and severity
(r =

.21,

p = .06), but was also not significant.

In the female subgroup a similar pattern of relationships

between post-dexamethasone Cortisol and clinical symptoms emerged.
In females, even stronger relationships were observed between post-
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.

dexamethasone Cortisol and guilt, somatic anxiety, psychosis,
and
age of onset of the illness.

In addition, a significant positive

correlation with endogeneity was observed in females. In the male
patients completely different associations were observed, with the
only significant correlations occurring between post-dexamethasone

Cortisol and the endogenous symptom psychomotor retardation
(positive correlation), and between post-dexamethasone Cortisol
and the nonendogenous symptom subjective anger (negative

correlation)
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TABLE

5

PARTIAL CORRELATIONS^ R KTWEEN PQST-n EXAMF.THA<^nMR rnPTTcny
AND
CLINICAL S YMPTOMS IN THE TOTAL GROUP OF PATTFMTg

Post-dexamethasone Cortisol: All patipnts (N=83

Guilt (H)^

Somatic anxiety

-.26
(

H)

Psychosis
Age of onset of

i llness

;

(S)^

.02

34

.002

26

.02

44

.01

(N=33)

Post-dexame thasone co r t i so 1

Guilt (H)

Females

(N = 52)

Males (N=31)

L

B.

L

Q.

39

.005

-.03

NS

38

.005

-.33

.07

Psychosis

34

.01

.03

NS

Age of onset (S)

56

.004

.20

NS (N=9)

Endogeneity

28

.05

.08

NS
.05

Somatic anxiety

(

H)

Psychomotor ret^

(S)

Subjective anger

(S)

-.

:

(N=24)

-. 14

NS (N=24)

.54

02

NS (N=25)

-.68

.

(N=14)

.005 (N=15)

^ Spearman correlations

(two-tailed) were computed after the
effects of age and severity on post-dexamethasone Cortisol had
been controlled for.
^ (H)= Item from Hamilton Depression Rating Scale
^ (S)= Item from Schedule for Affective Disorders and

Schizophrenia
^ ret= retardation

After Bonferroni correction, p values

43

<

.002 are significant.

In the unipolar major group (See Table

6,

p. 45),

none of the

endogenous symptoms correlated with post-dexamethasone Cortisol,
after the effects of age and severity had been removed. As

observed in the total group of patients, post-dexamethasone was
again significantly and negatively correlated with somatic
anxiety, and positively correlated with the age of onset of
illness. Additionally, in the unipolar major patients the length
of the current illness was observed to be negatively associated

with post-dexamethasone Cortisol.
In both unipolar females and males, the nonendogenous

symptom somatic anxiety was negatively and significantly

associated with post-dexamethasone Cortisol. Aside from this

common finding, different patterns of relationships between postdexamethasone Cortisol and symptoms emerged in females and males.
In female unipolar patients the only endogenous symptom to

correlate significantly (negatively) with post-dexamethasone
Cortisol was guilt. Significant positive correlations were also

observed in female unipolars between post-dexamethasone Cortisol
and the nonendogenous symptom obsessional ity, as well as with age
of onset of the illness. In male unipolars, three different

negative significant correlations were observed between post-

dexamethasone Cortisol and the following nonendogenous items:
gastrointestinal symptoms, somatic symptoms, and subjective anger.
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TABLE

6

PARTIAL CQRRELATIQNS^ RF.TWF.EN POST-nRV&f^f;T HASQNR mRTT^^ny,
CLINICAL SYMPTOMS TNI UKT^OIA R mYorT^T^^^^^^

An

P95t dexamethasone Cortisol:

iir^tp oiar

L
Somatic anxiety (H)

Length of illness

(S)

Da<-,ii>n»«i

rM=A7)

EL

-.38

Age of onset (S)^

ftMp

.001

.39

.05

(N=26)

-.38

.04

(N=29)

Post-dexameth^sone corti^n)

Fgmaleg (N=42)

L
Somatic anxiety

(H)

Age of onset (S)

Length of illness

(S)

Guilt (H)
Obsessional ity (H)

Gastrointestinal symptoms

Somatic Symptoms
Subective anger

(S)

.01

.49

.04

-.36

La

a

-.38

Males (N=25)

-.44

.03

(N=19)

.14

NS (N=7)

NS (N=20)

-.54

NS {N=9)

-.33

.03

.49

.03

12

NS

-.39

.05

.04

NS (N=41)

-.41

.04

11

NS (N=21)

-.58

.04

.

.

(N=19)

.006

NS

.24

NS (N=12)

(N=13)

^ Spearman correlations

(two-tailed) were computed after the
effects of age and severity on post-dexamethasone Cortisol had
been controlled for.
^ (H)

=

Item from Hamilton Rating Scale for Depression

^ (S)

= Item from Schedule for Affective Disorders and
Schizophrenia

After Bonferroni correction, p values
45

<

.003 are significant.

To more fully examine the relationship between
clinical

symptoms and post-dexamethasone Cortisol, a multiple
regression

analysis was performed on the total group of patients using
forced
entry of variables. In this analysis, variables which were

observed to be significantly correlated with post-dexamethasone
Cortisol, as well as age, sex and severity, were used as the

independent variables, and post-dexamethasone Cortisol was set as
the dependent variable.
.03)

This analysis identified three items (p

<

which accounted for a significant portion of the variance

(multiple R

=

.62,

R

square

=

.38,

p =

.001). These items were

psychosis and endogeneity which entered in a positive direction,
and guilt which entered in a negative direction.
In order to examine the clinical difference between

suppressors {N=59) and non-suppressors (N=24) of post-

dexamethasone Cortisol on the items of the HRSD,

a

discriminant

function analysis was performed. Only one symptom, paranoia, was a

significant contributor (p = .04) to the discriminant function
separating suppressors and non-suppressors. Patients were able to
be classified into suppressors and non-suppressors with only 51.8
% accuracy.

Post-dexamethasone Cortisol and suicide

Analysis of variance, covarying for the effects of age, sex,
and severity was used to compare the mean levels of post-

dexamethasone Cortisol in those patients with a rating of
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2

or

.

above on the HRSD suicide item (mean

Cortisol = 3.68

i

i

SD post-dexamethasone

4.12), and those patients with a HRSD suicide

rating of less than

2

(mean

i

post-dexamethasone Cortisol =4.11

4.65). No significant effects for either group (F

=

+

1.16, p = NS)

or covariates were observed.

In those patients with HRSD suicide ratings of

seven were non-suppressors, and

2

2

were suppressors.

with HRSD suicide scores of less than

2,

or above,

In patients

seventeen were non-

suppressors and 36 were suppressors (Chi square

=

.26,

df

=

p =

1,

NS)

Urinary free Cortisol (UFO and clinical symptoms

Table

7

lists all significant correlations between UFC and

clinical symptoms in the total group of patients and in the female
and male subgroups. In the total group of patients in whom urinary
free Cortisol was measured (N=38)

(see Table 7, p.

two

49),

endogenous symptoms, agitation and guilt, and two nonendogenous
symptoms, subjective anger and overt anger were observed to be

negatively and significantly correlated with urinary free Cortisol
after the effects of age, severity, creatinine and total volume of
urine had been controlled for. Correlations of only trend

significance were observed between UFC and age
and UFC and severity (r

=

.28,

p =

.09).

(r

=

.31,
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.06),

No significant

relationship was observed between UFC and endogeneity
= NS).

p =

(r

=

.11,

p

.

In the subgroup of females, significant
negative partial

correlations were again observed between urinary free
Cortisol and
the endogenous symptom agitation (as measured on
both the HRSD and

SADS), but not with guilt.

group,

In contrast to findings in the total

in females the nonendogenous symptoms paranoia (negative

correlation), and increased sleep (positive correlation, were also

observed to be significantly associated with urinary free
Cortisol
In the male subgroup of patients, a different pattern was

observed. As in the total group, subjective anger was negatively

correlated with UFC, however in males the endogenous symptom

retardation was also observed to be significantly and positively
correlated.
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TABLE

7

PARTIAL CORRELATIONS^ BETWEEN URINARV FRF.E CORTISQI. (UFO AND
CLINICAL SYMPTOMS IN THE TOTAL GROUP OF PATIENTS

TOTAL GROUP
UFC; All Patients (N=:^B)

L
Agitation

B.

-.60

.002

Guilt (S)^

-.41

.05

Subjective anger (S)

-.60

.002 (N=24)

Overt anger

-.63

.009 (N=23)

(H)

(S)

UFC: Females

L

-.27

NS (N= 10)

NS

(N = 13)

-.84

-.44

NS

(N= 12)

-.46

NS (N= 11)

-.68

.06

(N =12)

.31

NS (N = 10)

-.66

.03

(N =11)

-.55

NS (N==10)

-.06

NS

NS

Subjective anger (S)

-.41

Overt anger (S)

Agitation

(S)

Retardation

(H)

Increased sleep (S)

E.

(N= 14)

-.34

Paranoia

r

(N:=16)

NS

Guilt (S)

(S)

Males

-.38

.002

(H)

=23)

B.

-.60

Agitation

(N=24)

.69

.62

.009 (N==13)

.26

.

001 (N =11)

.02

NS (N==9)

^ Spearman correlations (two-tailed) were computed after the
effects of age, severity, creatinine and total volume on UFC had
been controlled for.
^

(H)= Item from Hamilton Rating Scale for Depression

^ (S)= Item from Schedule for Affective Disorders and

Schizophrenia
After Bonferroni correction, p values
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<

.003 are significant.

In the unipolar major group of patients
(see Table 8, p.
51), urinary free Cortisol again correlated
negatively with

agitation, as well as with another endogenous
symptom, psychomotor

retardation (positive correlation). In the unipolar
group, the
nonendogenous symptoms of subjective and overt anger
again

correlated negatively with urinary free Cortisol, and a
positive

correlation with the nonendogenous symptom obsessional ity was
observed as well.
In female unipolar patients,

fewer significant correlations

were observed, with only the correlation between urinary free

Cortisol and the endogenous symptom agitation attaining
significance. In the male unipolar subgroup, no significant

correlations with endogenous symptoms were seen, and the
relationships between urinary free Cortisol and nonendogenous
symptoms paralleled those of the total unipolar group; significant
partial correlations were observed between urinary free Cortisol
and subjective and overt anger, and a positive significant partial

correlation between urinary free Cortisol and obsessional ity was
observed as well.
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TABLE

8

~

PARTIAL CORRELATIONS^ BETWEEN URINA RY FREK mPTTgnr.
SYMPTOMS IN UNIPOLAR MAJOR PATIENTS

UFC; All Unipolar Patients

aKin

CLINICAL

(N=.l?.)

L
Agitation

(n)

47

.007

54

.02

Subjective anger (S)

65

.003 (N=19)

Overt Anger (b)

69

.002 (N=18)

UDsessionai 1 ty (S)

c

Psychomotor retardation

(

,51

S)

UFQ:

.04

(N=18)

(N=17)

Females (N=19)

Males (N=13)

L
Agitation

-.61

(H)

Obsessional ity (S)

.006

(N=19)

-.26

NS (N=13)

.11

NS (N=10)

.96

.00

(N=8)

Subjective anger (S)

-.28

NS (N=10)

-.77

.02

(N=9)

Overt anger (S)

-.61

Psychomotor retardation

(S)

.42

(N=9)

.08

NS (N=9)

-.73 .03 (N=9)
.40

NS (N=8)

^ Spearman correlations

(two-tailed) were computed after the
effects of age, severity, creatinine and total volume on UFC had
been controlled for.
^ (H)

= Item from Hamilton Rating Scale for Depression

^ (S)

= Item from Schedule for Affective Disorders and

Schizophrenia
After Bonferroni correction, p values

51

<

.003 are significant.

A multiple regresssion analysis using
forced entry of

variables was performed in the total group of patients
in order to
further explore the relationship bewteen urinary
free Cortisol and

clinical symptoms. In this analysis the dependent variable
was

urinary free Cortisol, and the independent variables were
those
that had been observed to be significantly correlated with
urinary
free Cortisol, as well as age, sex, severity, and suicidal

tendencies. Suicidal tendencies was entered as an independent

variable based on previous findings suggesting that past
suicidal ity may play a part in explaining the total variance of
UFC.

Overt anger, and subjective anger were significant negative

contributors, and suicidal tendencies, and severity were

significant positive contributors to the variance of urinary free
Cortisol (p

<

.05)

(multiple R= .63,

R

square

=

.40,

p

=

.0006).

Urinary free Cortisol and suicide

An analysis of variance covarying for the effects of age, sex
and severity was used to compare the mean levels of urinary free

Cortisol in those patients in the total group with a HRSD rating
of

2

or above

(mean

+

SD urinary free Cortisol = 105.66

i

and those patients with a HRSD suicide rating of less than
i

SD urinary free Cortisol = 97.48

for age

(F= 4.43, p = .04),

(F = 4.31,

p =

.05)

sex (F= 7.96, p

2

(mean

Significant effects

31.94).

i

44.49),

=

.008), and severity

were observed, however, the main effect for

group was non-significant (F= .05),
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P

= NS).

MHPG (3-methoxY-4-hvdroxvphenvlqlvcQn ^nH r linical svmnl-nm^

In the total group of patients (see Table
9, p. 54)

for whom

values for MHPG, creatinine and total urinary volume were

available (N=64), only the nonendogenous symptom depressed mood

correlated significantly and negatively with MHPG after the
effects of age, severity, creatinine and total volume on MHPG had

been controlled for. Neither age (r= .13, p = NS), severity
.11,

p = NS)

(r

=

nor endogeneity (r = -.02, p = NS) were significantly

correlated with MHPG in the total group. In the female and male
subgroups, again only nonendogenous symptoms were observed to

correlate significantly with MHPG, with paranoia correlating
positively with MHPG in females, and somatic symptoms correlating

positively in males.
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TABLE

9

PARTIAL CORRELATIONS^ BETWEEN 3-METH0XY-4-HY DRQXYPHF.NVr.rj.vrnT.
(MHPG) AND CLINICAL S YMPTOMS IN THE TOTAT. HRQUP qf PATTRMT.q

TOTAL GROUP
MHPG: All Patients

L
Depressed Mood

(H)*^

-.26

El

.04

MHPG; Females (N=42)

L
Depressed mood
Paranoia

(H)

(H)

Somatic symptoms

(H)

(N=f;4)

Males (N=22)

L

E.

E

-.22

NS

-.33

NS

.31

.05

-.31

NS

.46

.03

-.05

NS (N=41)

^ Spearman correlations (two-tailed) were computed after the
effects of age, severity, creatinine and total volume on MHPG had
been controlled for.
I-

(H)

= Item from

Hamilton Rating Scale for Depression

After Bonferroni correction, p values

54

<

.007 are significant.

In the unipolar major group (see Table 10,

p.

56)

the only

endogenous symptom to correlate significantly (positively) with
MHPG was agitation, and the only nonendogenous symptom to

correlate was obsessional ity

.

In the female subgroup, correlations

with agitation and obsessional ity were nonsignificant, however in
females MHPG correlated significantly with three other

nonendogenous symptoms: depressed mood (negative correlation),
paranoia, and number of suicide attempts (positive correlations).
In the male unipolar patients only the correlation between the

endogenous symptom agitation and MHPG attained statistical
significance.
In a multiple regression analysis performed on the total

group of patients,

in which MHPG was dependent and variables which

had attained significance in the correlation analyses, as well as
age,

sex, and severity were the independent varables,

sex,

agitation and obsessionality were found to contribute
significantly in

a

positive direction (p

MHPG (multiple R = .57, R square

=

.32,

<

p =

.05)

to the variance of

.0005).

These findings

did not appear to be due to an interaction effect of sex with

agitation and obsessionality, as sex was not significantly
correlated with either agitation

obsessionality

(r

=

.06,

p = NS).
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(r

=

.01,

p = NS)

or

TABLE 10

PARTIAL CORRELATIONS^ BETWEEN MHPG AND aJNTra r. SYMPTOMS IN
'
UNIPOLAR MAJOR PATIENTS
'

MHPG: All Unipolar Patients (N=K7)

Obsessionality

(H)*^

Agitation (S)^

.28

.05

(N=53)

.44

.01

(N=30)

MHPG: Females (N=42)
r

Obsessionality
Agitation

(H)

(S)

Depressed mood

Males (N = 25)
r

Bl

.21

NS (N=35)

.34

NS (N=18)

.28

NS (N=20)

.77

.009 (N=10)

.33

.05

(N=36)

-.10

Number suicide attempts

.49

.04

(N=18)

.00

NS (N=7)

Paranoia

.53

.04

(N=15)

-.40

NS (N=9)

(S)

(H)

NS (N=18)

Spearman correlations (two-tailed) were computed after the
effects of age, severity, creatinine and total volume on MHPG had
been controlled for.
(H)

^ (S)

= Item from Hamilton Rating Scale

for Depression

= Item from Schedule for Affective Disorders and

Schizophrenia
After Bonferroni correction, p values

56

<

.004 are significant.

MHPG and suicid^

A discriminant function analysis using
variables which had

been observed to be significantly correlated
with MHPG in zeroorder correlations, was performed in the total
group in order to

determine whether patients with "high" levels of
MHPG (using a

median split) could be separated from those with "low"
MHPG on the
basis of clinical symptoms. Only one symptom, suicidal
tendencies
(as rated on the SADS) was a significant contributor
(p = .005)

to

the discriminant function separating patients with "high" MHPG

from those with "low" MHPG. Patients were able to be classified
into" high" and "low" MHPG groups with 64.1 % accuracy.

An analysis of variance covarying for the effects of age,
sex, and severity was used to compare mean levels of MHPG in the

subgroup of patients with a score of
suicidal tendencies (N= 27) (mean
to those with a score of less than

tendencies (N = 12) (mean

±

3

and above on the SADS item

SD MHPG = 2585.11

+

3

i

1089.74)

on the SADS item suicidal

SD MHPG = 2087.33

significant effect for sex (F= 24.35, p

=

i

632.12). A

.000) was observed,

however a main effect for group did not attain significance (F =
.24,

P = NS).

In the total group of patients, a similar analysis of

variance, covarying for age, sex and severity was performed.

Patients with a HRSD suicide rating of
+ 2282

+

2

and above (mean

i

SD MHPG

718.64) were compared to those with a HRSD suicide rating

of less than

2

(mean

±

SD MHPG = 2496.28
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i

1001.79). Again, a

significant effect for sex (F = 32.22,
p = .000) was observed, as
well as a significant effect for severity
(F = 7.89, p = .007). A

significant main effect on MHPG was not observed
(F= 1.15, p =
NS).

Platelet monoamine oxidase (MAO) ^r t ivity

;.nH

M.inic;^i

In the total group of patients (See Table 11,

p.

..y n^pi-nnx.

60),

platelet MAO activity was not significantly correlated with
any

endogenous symptoms after the effects of age and severity on
platelet MAO activity had been controlled for. Platelet MAO
activity was also not observed to correlate significantly with
either age

(r

= .009,

p = NS),

or severity (r = .08, p = NS), and

although correlated more strongly with endogeneity
.06),

(r

=

.21,

p =

this correlation did not attain statistical significance.

Significant partial correlations were observed between platelet
MAO activity and the nonendogenous symptoms of suicide (positive

correlation), somatic anxiety, somatic symptoms, and genital
symptoms (negative correlations).
In the female subgroup a similar pattern was seen, with

platelet MAO activity again correlating with the nonendogenous
symptoms suicide, somatic anxiety, somatic symptoms, and in

addition correlating with obsessionality (positively). In females
the correlation between platelet MAO activity and genital symptoms

did not attain significance. Although no significant association

between platelet MAO activity and specific endogenous symptoms
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were observed, overall endogeneity was significantly
and

positively correlated with MAO in females. In males,
somatii
anxiety was again observed to be negatively correlated
with

platelet MAO activity, and a negative correlation with
para
was observed as well.
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TABLE 11

PARTIAL CORRELftTIONS^ R ETWEEN PLATE LET MONOAMTMP nvTnacF
ACTIVITY
AND CLINICAL SYMPTOMS IN THE TOTAL GROUP OF PATTRNT<^

TOTAL GROUP
Platelet MAO

Suicide

(H)*^

;

.26

All oatienhs (N=ftT)

.02

Somatic anxiety

(H)

-.32

.003

Somatic symtoms

(H)

-.27

.02

-.22

.05

Genital symptoms (H)

Platelet MAO: Females (N=62)
r

Suicide (H)

Q.

02 (N=51)

.32

Males (N=31)
r

BL

.02

NS

Somatic anxiety (H)

-.27

05

-.65

.001

Somatic symptoms (H)

-.30

03

-.21

NS

Genital symptoms (H)

-.27

06

-.12

NS

Endogeneity

.30

03

.04

NS

Obsessionality (H)

.45

001 (N=51)

-.21

NS

Paranoia

.09

NS

-.70

.01

(S)

(N=18)

(N=12)

^ Spearman correlations

(two-tailed) were computed after the
effects of age and severity on platelet MAO activity had been
controlled for.
^ (H)

= Item from Hamilton Rating Scale for Depression

^ (S)= Item from Schedule for Affective Disorders and

Schizophrenia
After Bonferroni correction, p values
60

<

.003 are significant.

In the unipolar major group (see Table
12, p. 63) platelet

MAO activity correlated significantly with overall
endogeneity,
however no relationship with specific endogenous symptoms
was
observed. As in the total group, platelet MAO activity correlated

significantly with the nonendogenous symptoms of suicide (positive
correlation), somatic anxiety, and somatic symptoms (negative
correlations). In addition, a negative correlation with paranoia
was observed.
In the female and male subgroups (see Table 13, p. 64), no

endogenous symptoms were significantly associated with platelet
MAO activity. In females only, overall endogeneity was observed to
be significantly correlated with platelet MAO activity. The

pattern of relationships between nonendogenous symptoms and
platelet MAO activity was completely different in female and male
patients. In the female subgroup, platelet MAO correlated

significantly with suicide, psychic anxiety, obsessional ity
(positive correlations), somatic symptoms and genital symptoms
(negative correlations).

In males, none of theses symptoms were

significantly related to platelet MAO activity. Instead,
significant negative correlations were observed between platelet
MAO activity and somatic anxiety, paranoia and depressed mood.
A multiple regression analysis was performed on the total

group of patients to further examine the relationship between

platelet MAO activity and clinical symptoms. In this analysis,

platelet MAO activity was the dependent variable, and the
independent variables (those which had attained statistical
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significance in the correlational analyses
as well as age, sex and
severity), were forced into the equation. Five
variables accounted
for a significant portion of the variance
(p
.66,

R square

=

.43,

p =

.0000).

Sex,

<

.05)

(multiple R =

somatic anxiety and somatic

symptoms entered negatively, and severity and current
suicidality
(HRSD), entered positively.
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TABLE 12

PARTIAL CORRELATIONS^ B ETWEEN PLATF.T. ET MQNnRMTMF nvTn^Qp
ACTIVITY
AND CLINICAL SYMPTOMS IN UNIPOLAR MAJOR PftTTRM?^

Platelet MAO:

All Unipolar Patients (M=f;7)

L

EL

Endogeneity

.26

.03

Suicide

.36

.003 (N=66)

(H)*^

Somatic anxiety

-.27

.03

Somatic symptoms (H)

-.30

.02

(N=66)

Paranoia (S)

-.40

.06

(N=25)

(H)

Spearman correlations (two-tailed) were computed after the
effects of age and severity on platelet MAO activity had been
controlled for.
^ (H)

=

Item from Hamilton Rating Scale for Depression

^ (S)

= Item from Schedule for Affective Disorders and
Schizophrenia

After Bonferroni correction, p values
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<

.002 are significant.

TABLE 13
NE OXIDA SE ACTIVITY
(MAO) AND CLINICAL SYMPTOMS IN UNIPOLAR MA.inp
FEMALES AND MALES

UNIPOLAR MAJOR GROUP
Platelet MAO
Females (N=42)
r

Endogeneity
Suicide

.

(H)*^

&

r

u

.15

NS

.24

NS

.35

.03

Somatic anxiety (H)

-.24

NS

Somatic symptoms

-.33

.04

Paranoia

(H)

-.11

(S)

Psychic anxiety

(H)

Genital symptoms (H)

(N=41)

-.18

NS

NS (N=15)

-.85

.002 (N=10)

-.36

.08

-.33

.04

Depressed mood

.14

(H)

.007

.01

.49

(N=41)

EL

-.53

.38

Obsessional ity (H)

Males (N=25)

(N=39)

.001 (N=41)

NS

-.02

NS (N=23)

-.16

NS

-.45

.02

Spearman correlations (two-tailed) were computed after the
effects of age and severity on platelet MAO activity were
controlled for.
(H)

= item from Hamilton Rating Scale for Depression

(S)

= Item from Schedule for Affective Disorders and

Schizophrenia
After Bonferroni correction, p values

64

<

.002 are significant.

Platelet MAO and snirir^o

Analysis of variance, covarying for the
effects of age, sex
and severity was used to compare the mean levels
of platelet MAO

activity in those patients in the total group with
of

2

or above (mean

±

SD MAO = 8.27

±

a HRSD rating

2.77 nanomoles of tryptamine

deaminated per hour per mg of protein), and those patients
with
HRSD suicide rating of less than
units).

2

(mean

+

SD MAO

=6.67

+

a

2.43

Significant main effects on platelet MAO activity were

observed for group (F = 5.52, p = .02), and for sex

(F = 8.32,

p =

.005).

Analysis of variance, covarying for the effects of age, sex,
and severity was also used to examine levels of platelet MAO

activity in the subgroup of patients for whom ratings on the SADS
item suicidal tendencies were available (N= 41). Higher levels of

platelet MAO activity were observed in those patients with ratings
of

3

6.91

or above on the item suicidal tendencies (mean
±

i

SD MAO =

2.15), as compared to patients with ratings of less than

on the suicidal tendencies item (mean

+

SD MAO = 6.53

significant effects for either covariates or group
NS) were observed however.
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+

(F =

3

2.02). No
.46,

p =

Ii>ter-relationsb1 p of post-dexamethasnnp rprtisol.
p l atelet MAP

activity and clinical ?vmptnf

|)5^

In the total group of patients, post-dexamethasone
Cortisol
was significantly correlated with platelet MAO activity
(r = .28,
p = .01)

(Spearman correlation, two-tailed). These two biochemical

measures correlated similarly with a number of specific clinical
symptoms.
In the total group of patients, significant negative

correlations were observed between somatic anxiety and both postdexamethasone Cortisol and platelet MAO activity. In addition,
both post-dexamethsone Cortisol and platelet MAO activity were

correlated similarly with overall endogeneity (r= .21, p = .06).
In the subgroup of females, somatic anxiety was once more

correlated with both biochemical measures. In addition,
endogeneity was observed to be positively and significantly
correlated with both post-dexamethasone Cortisol and platelet MAO
activity in females. In the male subgroup, there were no common
significant correlations between both biochemical measures and
specific clinical symptoms.
In the total group of unipolar patients, somatic anxiety was

again observed to be negatively correlated with both postdexamethasone Cortisol and platelet MAO activity. A similar
finding was observed in the male unipolar subgroup, however in the
female unipolar patients, the only symptom signicantly related to

both biochemicals was obsess ionality.
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In the total group of patients, MHPG
was significantly

correlated with UFC

(r

=

.47,

p =

.003)

(N = 38)

(Spearman

correlation, two-tailed). Despite the
association of these two
biochemicals,

few clinical symptoms were observed
to be

significantly correlated with both. In both the
total group of
patients and in the subgroup of males, there were
no similar

significant correlations. In the subgroup of female
patients,
paranoia was significantly correlated with both biochemicals,
however a positive correlation was observed between MHPG and
paranoia, while UFC was negatively correlated with paranoia.
In the total group of unipolar patients, obsessional ity was

positively correlated with both MHPG and UFC. Agitation was
significantly correlated with both biochemicals, however once
again, a significant positive relationship between MHPG and

agitation was observed, while UFC was negatively correlated with
agitatiton.

In neither the female or male subgroups were clinical

symptoms observed to be significantly correlated with both MHPG
and UFC.
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CHAPTER IV

DISCUSSION

Data in this study point to complex relationships
between
post-dexaraethasone Cortisol, urinary free Cortisol,
MHPG, platelet

MAO activity and clinical correlates. Several
general patterns did
emerge, however. Overall, stronger relationships were
observed

between the biological measures and specific clinical
symptoms
than with either endogeneity or severity of illness. A greater

number of significant correlations were observed between the
biological measures and nonendogenous symptoms of depression, than
with endogenous symptoms. In general, different patterns of

correlations were observed in the total group of patients as

compared to the unipolar patients, and in the female subgroup as

compared to the male subgroup. Sex differences observed in this
study must be interpreted with caution however, as the sample was

predominately female, and the relatively small sample size in the
male subgroup may have contributed to the fewer significant

correlations observed in males.

Relationships between post-dexamethasone Cortisol and endogeneity,
psychosis, and severity

In this study, endogeneity was found to be significantly

(positively) correlated with post-dexamethasone Cortisol in female
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patients only.

Although endogeneity was one of three significant

contributors to the total variance of post-dexamethasone
Cortisol,
the correlation between endogeneity and
post-dexamethasone

Cortisol in the total group did not attain statistical
significance. Overall these data suggest a significant yet weak

relationship between post-dexamethasone Cortisol and endogeneity.
While many studies have reported higher rates of DST non-

suppression in endogenously depressed patients (Coryell et al.,
1982; Feinberg & Carroll,

et al.,

1986;

Zhou et al

.

1984; Zimmerman et al

1987),

,

.

,

1985;

Zimmerman

few studies have examined

correlations between endogeneity and post-dexamethasone Cortisol.
One of the few studies to do so (Kumar et al

.

,

1986), reported a

moderate yet significant correlation between endogeneity and post-

dexamethasone Cortisol

(r

=

.27,

p =

.02), a finding consistent

with that of the present study.
In this study, post-dexamethasone Cortisol was found to be

more strongly related to endogeneity in female patients. While

previous studies have reported no sex effect on DST results (Asnis
et al.,
al.,

1982; Brown & Shuey,

1980; Carroll et al.,

1981; Maes et

1986), none of these have examined the relationship between

endogeneity and post-dexamethasone Cortisol levels separately in
females and males.

Data in this study point to a significant relationship

between post-dexamethasone Cortisol and psychosis. Psychosis was
found to be positively correlated with post-dexamethasone Cortisol
in both the total group of patients and in the subgroup of
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,

females.

In addition, psychosis was observed
to be one of three

significant variables to contribute significantly
to the total
variance of post-dexamethasone Cortisol. These
findings are

consistent with other reports of high levels of
post-dexamethasone
Cortisol in psychotic patients (Rothschild et al.,
1987).
In the current study,

the relationship between post-

dexamethasone Cortisol and severity of illness attained only
trend
significance. This finding is consistent with other reports of a
lack of association between post-dexamethasone Cortisol and

severity (Berger et al

.

,

1982;

Brown

Shuey,

&

1980;

Larsen et al

.

1985), but is in contrast with an even greater number of reports

finding severity to be positively associated with post-

dexamethasone Cortisol (Davis et al
Maes et al.,

1986;

Zhou et al.,

.

,

1981; Kumar et al

.

,

1986;

1987).

Overall, post-dexamethasone was observed to be weakly but

significantly related to endogeneity, strongly related

to

psychosis, and only very slightly related to severity. Based on
the results of the regression analysis,

it was

anticipated that

endogeneity, psychosis and guilt would be more strongly related to

post-dexamethasone Cortisol than other clinical signs and
symptoms, however this did not prove to be the case.

Post-dexamethasone Cortisol and endog enous symptoms

Many studies have reported an association between post-

dexamethasone Cortisol and specific endogenous symptoms of
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depression (Asnis et al
1982; Rubin et al.,

,

.

1985).

1982; Christensen et al.,

1986; Reus,

In the present study however, very few

significant relationships between post-dexamethasone
Cortisol and
endogenous symptoms were observed. This finding

is

consistent with

our observation of a weak relationship between overall
endogeneity

and post-dexamethasone Cortisol.
In this study, guilt was the only endogenous symptom to be

correlated (negatively) with post-dexamethasone Cortisol in the
total group of patients; this relationship was observed to be even

stronger in female patients. These findings are in contrast to

previous studies reporting a positive relationship between guilt
and post-dexamethasone Cortisol (Christensen et al., 1986; Reus,
1982;

Schatzberg et al

.

,

1987).

Psychomotor retardation, another endogenous symptom of
depression, was also found to be significantly (positively)

associated with post-dexamethasone Cortisol in the present study,
however this relationship attained statistical significance in
only the subgroup of males. This finding

is

consistent with other

reports of a significant positive relationship between post-

dexamethasone Cortisol and retardation (Agren
Schatzberg et al., 1987; Zimmerman et al

.

,

&

Wide,

1982;

1986), however in these

studies, post-dexamethasone Cortisol and retardation were observed
to be significantly related in combined groups of females and

males, rather than in males only.

Given the relatively small number of endogenous symptoms
observed to be significantly correlated with post-dexamethasone
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Cortisol, the findings from this study can be viewed as consistent

with reports of an overall lack of relationship between post-

dexamethasone Cortisol and specific endogenous symptoms (Asnis et
al.,

1982; Brown & Quails,

1981; Grunhaus et al

.

,

1985: Kaspar &

Beckman, 1983).

Post-dexamethasone Cortisol and nonendogenous symptoms

In this study, although stronger and more numerous

correlations were observed between post-dexamethasone Cortisol and
nonendogenous symptoms of depression, these correlations were

generally in a negative direction. The observation of very few
significant positive correlations between post-dexamethasone
Cortisol and nonendogenous symptoms is similar to the finding of
few positive relationships between post-dexamethasone Cortisol and

endogenous symptoms, and suggests that lower rather than higher
levels of post-dexamethasone Cortisol may be associated with the

presence of specific clinical symptoms of depression.
Of the nonendogenous symptoms to correlate significantly

with post-dexamethasone Cortisol, somatic anxiety was the most

strongly correlated, with significant negative relationships

appearing in all of the patient groups, with the exception of the
total male subgroup.

This finding is in contrast to previous

anxiety
reports which have found a positive association between

and post-dexamethasone Cortisol (Ceulemans et al., 1985;
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Christensen et al., 1986; Reus, 1982). These studies however,
have
not reported specifically on somatic anxiety, nor have they

examined post-dexamethasone Cortisol /anxiety relationships in
specific subgroups.
Two other symptoms related to somatic disturbance, somatic

symptoms, and gastrointestinal symptoms, were found to be

negatively correlated with post-dexamethasone Cortisol in the
group of male unipolar patients. These findings are in contrast to
a previous report of Christensen et al.

(1986),

in which ratings

on the HRSD items somatic symptoms and gastrointesinal symptoms
were combined into one score and found to be positively correlated

with post-dexamethasone Cortisol.

Differences between the

Christensen et al. study and the present one may be due both to
gender differences, as well as to the unipolar diagnosis, since in
the current study, positive yet insignificant relationships

between both somatic symptoms and gastrointestinal symptoms were
observed in the unipolar female group, while no significant

relationship was observed bewteen these symptoms and postdexamethasone Cortisol in the total group of patients.
In this study, the nonendogenous symptoms obsessional ity and

subjective anger were also found to be significantly related to

post-dexamethasone Cortisol. These correlations were significant
in only the unipolar female and male subgroups respectively, and

may reflect chance findings, as few reports of relationships

between these symptoms and post-dexamethasone Cortisol exist in
the literature.

Schatzberg et al.

73

(1987) did report finding a

significant correlation between
post-dexamethasone Cortisol and
obsessionality, however, this association
was in a negative

direction while in the current study

a

positive correlation was

observed.
Two other features of depressive
disorder, the age of onset
of the illness, and the length of the
illness were found to be

significantly related to post-dexamethasone
Cortisol in this
study.

The positive association between the age
of onset of

illness and post-dexamethasone Cortisol, observed
in the total

group of patients and the unipolar patients, with
stronger

relationships in females, has not previously been reported.
It

is

an intriguing finding however, as it suggests that age
of onset

may play a role in the biological expression of the disorder.
The other significant finding,

that of a negative

correlation between the length of the illness and postdexamethasone Cortisol in the group of unipolar patients, confirms
a finding of Sashidharan et al.

(1984),

in which it was

found that

non-suppressors of post-dexamethasone Cortisol at the time of
study had been ill for shorter periods of time. This finding, in

conjunction with that of the current study, suggests that higher
levels of post-dexamethasone Cortisol may be associated with

a

more acute form of the illness.

Post-dexamethasone Cortisol and discri minant function analvses

In the current study an attempt was made to replicate the

findings of Nasr et al.

(1983)
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in which a discriminant function

analysis was conducted using all the
items from the HRSD in order
to separate suppressors

from non-suppressors on the
DST on the

basis of clinical symptoms. While Nasr et
al.

(1983) reported

being able to discriminate suppressors from
non-suppressors with
92.5% accuracy on the basis of

clinical symptoms, in the current

9

study only paranoia (a variable not reported to
contribute to the

discriminant function in the study of Nasr et al.),
discriminated

between suppressors and non-suppressors, classifying patients
with
only 51.8 % accuracy.
The finding of the present study also failed to confirm the

report of Zimmerman et al.

(1985),

in which successful

discrimination between suppressors and non-suppressors was made on
the basis of five endogenous symptoms.

Differences between the present study and those of Nasr et
al.

(

1983) and Zimmerman et al.

(

1986), may be due to differences

in sample size, as the current study used twice as large a sample

as the Nasr et al.

(1983) study, and was approximately one-third

the size of the Zimmerman et al.

(

1986) study.

In addition,

the

inclusion of patients with psychotic features in the current study
may have confounded the results. An interaction effect between

paranoia and psychosis, which in this study were observed to be

significantly correlated

(r

=

.27,

p = .01), may have contributed

to paranoia being the only discriminating variable between

suppressors and non-suppressors, particularly since psychosis was

previously observed to be positively related to post-dexamethasone
Cortisol in this study.
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In this study no difference in degree
of suicidal ity was

found between supressors and non-suppressors
of post-dexamethasone

Cortisol, or between patients with either "high"
or "low" ratings
of current suicidality as measured on the HRSD.
In addition, post-

dexamethasone Cortisol was not observed to be correlated
with
suicide in either the total group or in any of the subgroups
of

patients
This finding is consistent with other reports which failed
to find a relationship between the DST and suicide (Brown et
al.,

1986; Secunda et al.,

1986; Zimmerman et al., 1986), but is in

contrast to those which have reported a positive association
(Banki et al., 1884; Coryell & Schlesser, 1981; Reus, 1982). In
the current study, although a continuum of suicidality was

examined, few patients were severely suicidal at the time of
study, a factor which may have affected the results. In general,
it appears that in this study,

suicidality was unrelated to HPA

dysregulation.

Urinary free Cortisol (UFO and clinical symptoms

Data in this study point to a stronger relationship between
UFC and specific clinical symptoms than between UFC and either

endogeneity or overall severity.

Although severity was one of the

four significant contributing variables to the variance of UFC,
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the correlation between UFC and severity
did not attain

significance.
Of the endogenous symptoms to correlate
significantly with
UFC, agitation was observed to be the most strongly
and most

frequently associated. This negative relationship between
UFC and

agitation was observed in both the total and unipolar groups of
patients, however when the sexes were examined separately,

significant correlations were observed only in females. The
finding of a sex difference in UFC/agitation relationships may be

partially an artifact due to the predominance of females in this
sample.

Retardation, another measure of psychomotor disturbance, was
found to be positively and significantly correlated with UFC in
the unipolar group and in the total subgroup of males. This

observation of a positive relationship between UFC and
retardation, and a negative relationship between UFC and
agitation, suggests that retardation and agitation may be opposite

manifestations of a common underlying psychomotor disturbance,
which is in turn related to UFC.
While no other reports of associations between psychomotor

disturbance and UFC exist in the literature, several studies of

post-dexamethasone Cortisol, another measure of HPA dysfunction,
have reported positive associations with either agitation or

retardation (Agren
al.,

& Wide,

1982; Asnis et al., 1982; Zimmerman et

1986).
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In the current study, the endogenous symptom guilt was also

found to be negatively correlated with UFC in the total group of

patients. Again, this finding has not been reported in the

literature, however, it is consistent with our previous finding of
a negative relationship between post-dexamethasone Cortisol and

guilt.
Of the nonendogenous symptoms to correlate significantly

with UFC (subjective anger, overt anger, paranoia, increased
sleep, and obsessionality )

,

only the relationships between

subjective and overt anger and UFC have been reported in the
literature. Further studies are needed to determine whether the

significant relationships observed in the present study between
UFC and paranoia, increased sleep and obsessionality are simply

random findings.
In this study, negative correlations were observed between

UFC and both subjective and overt anger as measured on the SADS.
These relationships were observed in both the total group of

patients and in the unipolar group, but were strongest in males.
This finding is consistent with a previous report of Agren & Wide
(1982)

in which significant negative correlations between anger

scores on the SADS and UFC were observed.
Both the present study and the study of Agren & Wide (1982)

also point to a relationship between anger, UFC, and suicidal ity.

Agren & Wide (1982) found that seriousness plus medical lethality
of worst ever suicide attempt, subjective anger, and overt anger

(contributing in a negative direction) explained 20% of the
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variance of UFC. In the present study, subjective
anger and overt
anger were also found to contribute negatively to the
variance of
UFC, however suicidal tendencies and severity
contributed in a

positive direction, with all four items explaining 40% of the
total variance of UFC.
In contrast to the study of Agren & Wide (1982) in which UFC

was associated with less suicide proneness and less anger, in the

present study, UFC was associated with less anger, but greater
suicidal ity. Differences between the two studies may partly be

accounted for by the differing measures of suicidality. Agren

&

Wide's finding related to the worst ever suicide attempts, while
in the present study, suicidal ideation occurring during the worst

week of the current episode was measured by the SADS item suicidal

tendencies.
The finding of a negative relationship between UFC and both

subjective and overt anger, and a positive association with
suicidality, suggests that patients who experience or display less
anger may be more likely to have higher UFC levels and may be more

suicidal as well. In this study however, we were unble to find

significant differences in levels of UFC between patients with
either "high" or "low ratings of current suicidality as measured

on the HRSD.
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In this study no significant relationship was observed

between MHPG and endogeneity. While few studies have reported on
the relationship between endogenous status and MHPG, one study

(Nelson & Charney, 1981) suggested that decreased MHPG may be

specific to endogenous depression. The results of the present
study failed to support this hypothesis.

Severity of illness was also found to be unrelated to MHPG
in the current study. This finding is consistent with many other

reports of a lack of an association between severity and MHPG
(Davis et al,, 1981; Redmond et al., 1986; Roy et al., 1986).
In this study,

the only endogenous symptom to correlate with

MHPG was agitation. This correlation attained significance in the

unipolar group of patients only, and was considerably stronger in
males. Agitation was also observed to be one of three variables
to contribute significantly to the total variance of MHPG.

A

significant relationship between agitation and MHPG has not
previously been reported in the literature to our knowledge,
however another symptom of psychomotor disturbance, retardation,
has been found to be positively associated with MHPG (Redmond et
al.,

1986). It is possible that overall psychomotor disturbance is

related to higher levels of MHPG, and that in unipolar patients,

particularly males, this is expressed in the form of agitation,
while in other diagnostic groups or in females, it is expressed as

retardation.

80

The significant correlations between MHPG and nonendogenous

symptoms (depressed mood, paranoia, somatic symptoms and

obsessionality) were relatively weak, and generally differed from
the nonendogenous symptoms reported to be significantly related to

MHPG in the literature. Only the item somatic symptoms which in
the current study was observed to be positively and significantly

correlated with MHPG in males, has been discussed in previous
reports. Redmond et al.

(1986)

found that depressed patients with

increased somatization had higher levels of CSF MHPG, and Agren
(1980)

found that "somatic preoccupation" was one of four symptoms

to characterize a "high" MHPG group. Further studies are needed in

order to determine whether the findings in the current study

relating the nonendogenous symptoms of depressed mood, paranoia,
and obsessionality to MHPG can be replicated, or are due more to

chance findings.

MHPG and suicide

In this study relationships between MHPG and suicide

differed, depending upon whether ratings of past or present
suicidal ity was assessed (SADS vs. HRSD), and the statistical

method used. Using ANOVA, higher levels of MHPG were observed in
those patients with greater past suicidal ity (measured on the SADS

item suicidal tendencies), as compared to patients with lower
not
levels of past suicidality, however these differences were
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statistically significant. In contrast, the
SADS item suicidal
tendencies was found to discriminate significantly
between a
"high" and "low" MHPG group, with the "high"
MHPG group associated

with greater past suicidality.

Agren (1980) also using discriminant function analysis,
found the SADS item suicidal tendencies to be one of six

discriminating variables differentiating between patients with
high and low MHPG. In his study, however, Agren found MHPG to be

negatively associated with suicidal tendencies, while in the
present study MHPG was positively yet insignificantly related to
MHPG.

In contrast to the finding of a positive association between

MHPG and past suicidality using the SADS, a negative non-

significant relationship was observed between MHPG and HRSD
ratings of suicidality occurring at the time of biochemical
measurement. Lower levels of MHPG were observed in patients with
higher ratings of current suicidality (measured by the HRSD

suicide item), as compared to patients with lower ratings of

current suicidality. Again, these differences did not attain
statistical significance. The finding of a negative relationship

between MHPG and suicidality

is

consistent with the previously

mentioned report of Agren (1980), as well as with a report of
Secunda et al.

(1986)

in which suicide attempters were found to

have significantly lower urinary and plasma MHPG levels than

patients who had never attempted suicide. In the present study
however, only ratings of suicidality occurring at the time of
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biochemical measurement were negatively related
to MHPG, while in
the reports of Agren (1980) and Secunda et
al.

(1986), ratings of

past suicidality were negatively associated with
MHPG.
The findings of the current study point to the

methodological difficulties involved in studying suicide,
and
suggest that some of the discrepancies in reports of relationships

between suicidality and MHPG may be due to differences in methods
of assessment of suicidality.

Relationships betw een platelet MAO activitv and endoaeneity
and severity

In this study, a significant positive relationship was

observed between platelet MAO activity and endogeneity in the
total group of unipolar patients. Uhen data from females and males

were analyzed separately however, this association was significant
in females only, with significant positive relationships observed
in both the total and unipolar female subgroups. This data

suggests that the association between platelet MAO activity and

endogeneity is affected both by gender and diagnosis.
Previous reports have found platelet MAO activity to be
higher in women (Bridge et al., 1985; Mann, 1979; White et al.,
1983), a finding which may partially account for our observation

of a stronger association between endogeneity and platelet MAO
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activity in females. In addition, the finding
of a positive

association between platelet MAO activity and endogeneity
in
unipolar patients only, is consistent with a study of
Samson et
al.

(1985)

in which higher platelet MAO activity was
reported in

unipolar endogenously depressed patients compared to bipolar

endogenous patients or unipolar nonendogenous patients.
In contrast to several reports (Gudeman et al., 1982; Mann,
1979; Samson et al.,

1985),

in the current study no significant

correlation was observed between platelet MAO activity and
severity of the illness. Severity of illness was however, one of
five variables to contribute significantly to the total variance

of platelet MAO activity, which suggests that perhaps an

interaction effect between severity and other clinical symptoms
exists. This study included four patients who were only mildly

depressed (total HRSD score less than 18), which may have

contributed to the lack of significant association between
platelet MAO activity and severity.

Platelet MAO activity and clinical symptoms

In this study, no endogenous symptoms of depression were

observed to correlate significantly with platelet MAO activity.
This finding is unexpected given the previously observed

significant relationship between platelet MAO activity and overall
endogeneity. The present finding is in contrast to previous
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reports which have found a negative association
between MAO

activity and the endogenous symptom guilt
(Perris et al., 1980;
Perris et al., 1984; Schalling et al., 1980),
and positive

associations between platelet MAO activity and various
forms of
sleep disturbance (Agren & Oreland, 1982; Schatzberg
et al.,
1985).

In this study, several significant relationships between

platelet MAO activity and nonendogenous symptoms were observed.
Of
these, somatic anxiety was the roost strongly correlated, with

significant correlations observed between platelet MAO activity
and somatic anxiety in all the patient groups with the exception
of the subgroup of unipolar females. This finding is in direct

contrast to studies by Davidson et al. (1980) in which a positive

association was observed between platelet MAO activity and
anxiety, and Georgotas et al.

(1986) in which platelet MAO

activity was found to be positively correlated with somatic
anxiety. In the study of Georgotas et al., psychic anxiety was
found not to relate significantly to platelet MAO activity, while
in the present study psychic anxiety was significantly and

positively correlated with MAO In unipolar females, and
negatively, although insignificantly correlated with platelet MAO

activity In unipolar males.
Athough not previously reported In the literature, the
present data point to an overall negative association between

platelet MAO activity and symptoms which are related to somatic
disturbances. In addition to the negative correlation observed
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between platelet MAO activity and somatic anxiety, negative
correlations were also observed between platelet MAO activity and
both somatic and genital symptoms, with somatic symptoms

correlating with platelet MAO activity in both the total and
unipolar groups as well as in the respective female subgroups, and
genital symptoms correlating with platelet MAO activity in the
total group. These findings suggest that lower levels of platelet

MAO activity may be associated with greater physiological

disturbance which manifests itself in somatic symptoms.
The other nonendogenous symptoms observed to be

significantly correlated with platelet MAO activity in this study,
obsessional ity, paranoia, and depressed mood, have also not

previously been reported in the literature. In females, higher
platelet MAO activity was observed to be associated with more
obsessional thinking, while in males and in unipolar patients,
lower platelet MAO activity was observed to be related to

paranoia. The correlation between depressed mood and platelet MAO

activity attained significance in only the subgroup of male
unipolar patients. Previous studies have reported relationships

between these symptoms and post-dexamethasone Cortisol (Schatzberg
order to
et al., 1987), however, further research is needed in
paranoia,
determine whether relationships between obsessional ity,

more than random
and depressed mood and platelet MAO activity are

findings.
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Platelet MAO activity

anri

'^y^y^/^^

Of the four biochemical measures of depression studied,

platelet MAO activty was the most stongly associated with
suicidal ity. Positive correlations were observed between platelet

MAO activity and suicide in both the total and unipolar groups.

When the sexes were examined separately, this relationship was

observed to be strongest in females. In the regression analysis,
suicide was observed to be one of five variables to explain the
total variance of platelet MAO activity.

Levels of platelet MAO activity were also observed to be

significantly higher in patients with higher ratings of current
suicidal ity (assessed at the time of biochemical measurement using
the HRSD suicide item) as compared to patients with lower current

suicide ratings, even after the effects of age, sex, and severity
had been controlled for. This finding suggests that the positive

association observed between platelet MAO activity and suicide

is

not due simply to the higher levels of platelet MAO activity

observed in women. Although not significant, higher levels of
platelet MAO activity were also observed in patients with higher
ratings of past suicldality (based on ratings from the SADS
suicidal tendencies item) as compared to patients with lower

ratings of past suicldality.
The present study is one of the first to report a positive

association between platelet MAO activity and suicide. Other
studies have either reported a negative relationship (Gottfries et
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al., 1980, Buchsbaum et al., 1981), or no
relationship between

MAO activity and suicide (Oreland et al., 1981; Reveley
et al.,
1981). Data in this study may differ from previous reports
due to

several factors. Unlike other studies, in this study, significant

positive associations between platelet MAO activity and
suicidal ity were observed when both ratings of current suicidal ity
and biochemical measurement were obtained during the same one week
period.

In addition,

the current study focused on depressed

patients only, rather than examining suicide across diagnostic
groups. The methodological approach used in this study may have

contributed to the contrasting findings.

Inter-relationship of post-dexamethasone Cortisol, platelet MAO
activity and clinical symptoms

In this study post-dexamethasone Cortisol was observed to

correlate positively and significantly with platelet MAO activity.
This finding is consistent with previous reports of a positive

association between these two biological meaures (Meltzer et al.,
1988; Schatzberg et al.,

1983b; Schatzberg et al., 1985;

Schatzberg et al., 1987). It must be noted however, that in two of
these studies (Schatzberg et al., 1983b and Schatzberg et al.,
1985), a subset of patients (N = 26 and N = 50 respectively) from
the current study were reported on.
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Although the biological relationship between these two
measures remains unclear, it

is

possible that both are related to

an endogenous subtype of depressive disorder. In this study post-

dexamethasone Cortisol and platelet MAO activity were observed to
be identically although insignificantly correlated with

endogeneity

(r

=

.21,

p = .06), as well as being significantly and

positively correlated with endogeneity in the subgroup of females.
In this study no significant correlations were observed

between either post-dexamethasone Cortisol or platelet MAO
activity and severity. This finding
Schatzberg et al.

is

in contrast to the study of

(1985) which found both measures to be modestly,

but significantly, correlated with total HRSD scores in a subset
(N = 50) of the same

patients currently studied.

The one symptom that was observed to be negatively

correlated with both post-dexamethasone Cortisol and platelet MAO
activity in the total group, as well as in several of the
subgroups (the total female group, the unipolar group and the

group of unipolar males) was somatic anxiety. This finding

contrasts with a hypothesis proposed by Georgotas et al. (1986)
which suggests that platelet MAO activity is associated with

higher anxiety and agitation, symptoms which in turn account for
some cases of DST non-suppression. The current findings suggest

rather, that a lack of anxiety, at least of a somatic type, may be

associated with higher levels of post-dexamethasone Cortisol and
platelet MAO activity, and that overall, higher levels of both

89

biological measures may be related to
a depressive syndrome
involving more endogeneity and less anxiety.

^ntgr-relationshin of MHPG. UFr and minir;>i
^^YTt-m

In this study MHPG was observed to correlate
positively and

significantly with UFC in the total group of patients for
whom
these measures were available. This finding is consistent
with a

report of Rosenbaum et al.

(1983) and others which found strong

significant relationships betwen these two biological measures.
In this study neither MHPG nor UFC were significantly

correlated with either severity or endogeneity. In addition, no
clear pattern emerged between both of these biological measures

and clinical symptoms. Obsess ionality was observed to be

significantly and positively correlated with both MHPG and UFC in
the group of unipolar patients, however the other two symptoms

(paranoia and agitation) observed to be significantly correlated

with both measures were correlated in opposite directions with

each biological measure. Since only a subset of the sample (N= 38)
had both MHPG and UFC measurements, it is possible that the

overall lack of associations between these two measures and

clinical symptoms is due to the small sample size, and that more

meaningful relationships would emerge in a larger sample of
patients.
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total g rnnp

In this study separate correlation
matrices were calculated
for the total group of patients (a combined
group of unipolar and

bipolar patients), and for the unipolar group
of patients. Given
the more homogeneous nature of the unipolar
group, it was

anticipated that to some extent, different patterns of
relationships between the biological measures and clinical
symptoms would be observed in the unipolar group, while also

anticipating a large degree of overlap between findings in the
two groups due to the majority of the total sample being diagnosed
as unipolar. As anticipated, several variables were observed to be

significantly correlated with the biological measures in the
unipolar group, but not in the total group, and in some cases
stronger associations were observed in the unipolar group as

compared to the total group.
In the correlations between post-dexamethasone Cortisol and

clinical symptoms, the variables that were observed to be

significantly correlated in the unipolar group but not in the
total group were length of illness (significant in the total

unipolar group), somatic symptoms, and obsessional ity (significant
in the unipolar female subgroup).

A stronger

relationship between

post-dexamethasone Cortisol and somatic anxiety was observed in
the unipolar group.
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In the correlations between UFC and
clinical symptoms in the

unipolar group, relationships emerged
between UFC and psychomotor

retardation (in the total unipolar group) and
obsessional ity (in
the male subgroup);

these relationships were not observed
to be

significant in the total group. The association
between overt
anger and UFC was stronger in the unipolar group
of patients than
in the total group, although in both, the correlations
were

statistically significant.
Significant relationships between MHPG and obsessional ity,
agitation, (in the total unipolar group) and number of suicide

attempts (in the unipolar female subgroup) were observed in
unipolar patients but not in the total group of patients.
In the correlations between platelet MAO activity and

clinical symptoms, two variables, endogeneity and paranoia, were

significantly related to platelet MAO activity in the total
unipolar group, but not in the total group of patients. Psychic

anxiety was also observed to be significantly related to platelet
MAO activity in unipolar females but not in the total group of
females. An even stronger relationship was observed between

platelet MAO activity and suicide in the unipolar group as

compared to the total group, although again in both, the
correlations were significant.
These data point to the usefulness of studying subtypes of

depressive disorders. Although not reported in this study,
different relationships between biological measures and clinical
symptoms were observed in the bipolar group of patients. The data

92

.

presented here suggest that symptom
patterns may vary in subtypes
of depressive disorders and that
these symptoms may relate

differently to biological measures in
subtypes of depressive
disorders

PeUtjonships between biological

mp;..nr.s and rlinin.i

symptom., in

female and male p atipnt-<s

In this study a greater number of significant
correlations

were observed between biological measures and clinical
symptoms in
the female group of patients than in the male subgroup.
As stated

previously, this finding may be due to the larger sample size
of
the female subgroup, but may also reflect differences in both

biological measures and in symptom patterns in females and males.
Very few symptoms were observed to correlate significantly
with the biological measures in both the female and male
subgroups. In fact, almost completely opposite patterns of

relationships were observed in female and male paients. While
these differences will not be discussed in detail here. Tables

5

through 13 demonstrate this pattern clearly.
Of the many symptoms examined in this study, only two were

correlated similarly and significantly with biological measures in
females and males. Somatic anxiety was correlated significantly

with post-dexamethasone Cortisol in both unipolar females and
males, as well as being correlated significantly with platelet MAO
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activity in the total female and
male subgroups. Guilt was
significantly correlated with
post-dexamethasone Cortisol in both
the unipolar female and male subgroups.

Further studies are needed in order
to help determine

whether the greater number of symptoms
observed to be related to
biological measures in females in this study,
is due to increased

symptomatic complaints in females, different
biological mechanisms
in females and males, or can simply be
attributed to random

findings.

Summary

In this study complex relationships were observed between

biological measures and clinical correlates in a total group of 83
patients, a subgroup of 67 unipolar major patients, and in female

and male patients in these two groups. Data from all correlations

which attained significance levels of p

<

.05 were presented and

discussed in an attempt to most fully explore the relationships

between four biological measures of depression and clinical signs
and symptoms. Due to the large number of correlations calculated
in this study however,

the risk of a Type II error (a false

positive identification of significance due to chance alone) was
quite high. After adjusting statistically for this possibility

using the Bonferroni correction, fewer, yet significant

correlations were still observed between the biological measures
and clinical correlates. These statistically more robust
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correlations, in conjunction with the regression analyses, provide
the most reliable data concerning relationships between biological

measures and clinical correlates.
The four key symptoms observed to be related to post-

dexamethasone Cortisol based on the more stringent criteria were
somatic anxiety, guilt, psychosis and endogeneity. Three of these
symptoms, guilt, psychosis and endogeneity explained 41 % of the
total variance of post-dexamethasone Cortisol, while somatic

anxiety was observed to be significantly correlated with post-

dexamethasone Cortisol in the total and unipolar groups even after
Bonferroni correction.
UFC was observed to be primarily related to five symptoms
(overt anger, subjective anger, suicidal tendencies, agitation,

and obsessional ity), as well as to sex and severity after more

stringent statistical criteria were applied. As reported earlier,

overt anger, subjective anger, suicidal tendencies, sex, and
severity explained 41 % of the variance of UFC. Correlations

between UFC and agitation and UFC and subjective anger remained
statistically significant in the total group, after Bonferroni
correction, as did correlations between UFC and agitation,

subjective anger, and overt anger in the unipolar group.
the
Obsessional ity remained significantly correlated with UFC in

male unipolar subgroup after statistical correction.

between MHPG and
No significant correlations were observed
The regression
clinical symptoms after Bonferroni correction.

were observed
analysis in which sex, agitation, and obsessionality
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to explain 32 % of the total variance
of MHPG probably provides

the best measure of relationships between
MHPG and clincal

symptoms.
The five key symptoms observed to be related
to platelet MAO

activity using more stringent statistical criteria
were somatic
anxiety, suicide, somatic symptoms, obsessional
ity, and paranoia,
as well as sex and severity. Forty-three percent
of the variance

of platelet MAO activity was explained by somatic anxiety,
suicide, somatic symptoms, sex, and severity. Somatic anxiety
was

also observed to correlate significantly with platelet MAO

activity in the total group and total group of males after
Bonferroni correction. In the female subgroup and in unipolar
males, obsessionality remained significantly correlated with

platelet MAO activity after statistical correction, as did
paranoia in the subgroup of unipolar males.
These data point to essentially unique relationships between

each of the four biochemicals and clinical symptoms. Only three of
the symptoms, somatic anxiety, agitation, and obsessionality were

observed to correlate with more than one biochemical measure after
Bonferroni correction. Further studies are needed to explore
whether even these more robustly related symptoms are best

explained by chance alone, or can be replicated in the future.
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APPENDIX

Hamilton Rating Sc ale for neoressin^^

Depressed
0.
1.
2.
3.

4.

Mnor^

Absent
These feeling states indicated only on
questioning
These feeling states spontaneously reported
verbally
Communicates feeling states non-verbally-i.e.
through
,
facial expression, posture, voice, and tendency
to weep
Patient reports virtually only these feeling
states in his
spontaneous verbal and non-verbal communication

Feelings of Guilt
0.
1.
2.

3.

4.

Absent
Self-reproach, feels he has let people down
Ideas of guilt or rumination over past errors or sinful
deeds
Present illness is a punishment, delusions of guilt
Hears accusatory or denunciatory voices and/or experiences
threatening visual hallucinations

Suicide
0

.

1.
2.

3.

4.

Absent
Feels life is not worth living
Wishes he were dead or any thoughts of possible death to
self
Suicide ideas or gesture
Attempts at suicide (any serious attempt rates 4)

Insomnia Early
0.
1.

2.

No difficulty falling asleep
Complains of occasional difficulty falling asleep - i.e.
more than 5^ hour
Complains of nightly difficulty falling asleep

Insomnia Middle
0.

No difficulty

1.

Patient complains of being restless and disturbed during the
night
Waking during the night - any getting out of bed rates 2
(except for purposes of voiding)

2.
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6

Insomnia

.

Lat-p

0.

No difficulty

2*
2.

°^
""^'^^^^ but goes back to sleep
nn^i?! to
i"" fall
Unable
asleep again if gets out of bed

f

Work and ActivitiPR

7.

No difficulty
Thoughts and feelings of incapacity, fatigue
or weakness
related to activities work or hobbies
2. Loss of interest in activity: hobbies or
work- either
directly reported by patient, or indirectly in
listlessness,
indecision and vacillation (feels has to push self
to work
or activities)
3. Decrease in actual time spent in activities or
decrease in
productivity. In hospital, rate 3 if patient does not spend
at least three hours a day in activities (hospital job or
hobbies) exclusive of ward chores
4. Stopped working because of present illness. In hospital,
rate 4 if patient engages in no activities except ward
chores, or if patient fails to perform ward chores
0.
1.

unassisted

Retardation

8.

0.
1.

2.
3.

4.

Agitation

9.

0

.

1.

2.

10

Normal speech and thought
Slight retardation at interview
Obvious retardation at interview
Interview difficult
Complete stupor

.

None
"Playing with" hands, hair etc.
Hand-wringing, nail biting, hair-pulling, biting of lips
etc.

Anxiety Psychic
No difficulty
Subjective tension and irritability
2. Worrying about minor matters
3. Apprehensive attitude apparent in face or speech
4. Fears, expressed without questioning
0.

1.
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Anxiety

11.

Snmai-^r^

0

Absent

2

Moderate

\\

ttlT

4.

Incapacitating

Somatic Symptoms

120

.

^'

{

{

fla

Physiological concomitants of
anxiety,
'"''5 as: Gastrointestinal- dry mouth:

^^-P^'
b^fchiig'^'"''^^'
cardio-vascular- palpitations,
headaches,
respiratory- hyperventilation,
sighing,
urinary frequency, sweating
stro-lnhpsh nai
i

None
but eating without staff encouragement.
Heavy feelings
abdomen
Difficulty eating without staff urging,
requests or requires
laxatives or medication for bowels or
medication for G I
symptoms

m

2.

Somatic Svmptoms General

13.
0

.

1.

2.

14.

15.

None
Heaviness in limbs, back or head. Backaches, headache,
muscle aches, loss of energy and fatigability
Any clear-cut symptom rates 2

Genital Symptoms
0,

Absent

^'

'^ll^

2.

Severe

Symptoms such as: Loss of libido
Menstrual disturbances

Hypochondriasis
Not present
Self-absortion (bodily)
2. Preoccupation with health
3. Frequent complaints, requests for help, etc.
4. Hypochondriacal delusions
0.
1.

16.
A.

Weight Change

When rating by history (pre-treatment)
0. No weight loss
1. Probable weight loss associated with present illness
2. Definite (according to patient) weight loss

99

Weight Chang e

16.
B.

On weekly ratings by ward psychiatrist,
when actual weight
weignt
changes are measured
0. Less than 1 lb. weight loss in one
week
1. One to 2 lb. weight loss in one
week
2. Greater than 2 lb. weight loss in
week
Insight

17.

0.
1.

2.

Acknowledges being depressed and ill
Acknowledges illness but attributes cause to
bad food,
climate, overwork, virus, need of rest etc.
Denies being ill at all

Diurnal Variation

18.

0.
1.

2.

Absent (no variation in symptoms a.m. /p.m.)
Mild (minimal variation in symptoms a.m. /p.m.)
Severe (significant variation in symptoms a.m. /p.m.)

Depersonalization and Derealization

19.

0.
1.
2.
3

.

4.

Absent
Such as: Feelings of unreality, nihilistic
Mild
ideas
Moderate
^
Severe
Incapacitating

Paranoid Symptoms

20.

None
Suspicious
2. Ideas of reference
3. Delusions of reference and persecution
4. Persecutory hallucinations
0

.

1.

21.

Obsessional and Compulsive Symptoms
0.
1.
2.

Absent
Mild
Severe
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